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ABSTRACT 
Herpetic stromal keratitis (HSK) is an immunopathological and tissue destructive 
corneal lesion caused by herpes simplex virus (HSV) infection, which induces an 
intense inflammatory response and finally leads to blindness. Accumulating 
evidence using the murine model has shown that Th-1 phenotype CD4+ T cells 
orchestrating the inflammation mainly contribute to the immunopathological 
reaction in HSV-1 infected cornea. However, prior to CD4+ T cell infiltration into 
corneal lesions, various innate immune cells recruit and produce numerous 
inflammatory and angiogenic molecules into the corneal stroma those in turn drive 
the corneal immunopathology.  
The first part (Part I) of this dissertation focuses on the understanding of 
HSV-1 induced immunoinflammatory processes in the cornea and trigeminal 
ganglia including the secondary lymphoid tissues. The next three parts (Part II-IV) 
focus on different inflammatory and anti-inflammatory mechanisms that are 
activated following virus infection in the cornea. Results in Part II evaluate the role 
of various Toll-like receptors (TLRs) in driving the early inflammatory events that 
occur in the HSV infected corneas. Thus, this part demonstrates that mainly TLR2 
and to a lesser extent TLR9 ligand activity of HSV is important for driving SK 
pathology. Results of the third section show that HSV infection results in the up 
regulation of IL-23 that is needed for the survival of pathogenic Th-17 cells. The 
data show that mice lacking IL-23 were more susceptible to SK lesions and that the 
heightened lesion severity was attributed to higher IL-12 production and Th1 
immune response in such animals. The fourth section describes the relative role of 
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IL-10 and natural regulatory T cells (nTregs) as two independent anti-inflammatory 
mechanisms that are needed for controlling HSK lesions.  
In this study, experiments were designed to understand the mechanisms 
involved in the induction and regulation of immunopathology in HSK and 
modulation of such processes could be useful in designing therapeutic for HSK.  
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Part-I 
Background and overview 
 1
CLINICAL BACKGROUND 
Herpes simplex virus (HSV) induced eye diseases are one of the commonest 
causes of unilateral infectious blindness in the western world [1]. Epidemiological 
studies in the United states reveal that, 400,000 persons are affected, with 20,000 
new cases occurring annually with the incidence ranging from 4.1- 20.7 cases/100 
000 patients per year [2]. Results from surveys conduced by the National Health 
and Nutrition Examination between 1976 and 1980 (NHANES II) and again 
between 1988 and 1994 (NHANES III) showed a 30% increase in HSV-2 specific 
antibodies within the studied timeframe in the United States [3]. In contrast the age 
specific seroprevalence of HSV-1 has decreased in the industrial countries with an 
exception to several developing countries [3]. Ocular lesions are mostly caused by 
HSV type 1 and very rarely by HSV type 2 infections. However, 80% of neonatal 
herpes infection is caused by HSV-2 although both strains can be involved. 
Classically, the life cycle of HSV in the host is divided into four stages 
namely, entry, spread, establishment of latency and reactivation. After the primary 
infection of the skin or mucosal surfaces with HSV, it spreads to the neuronal cell 
bodies where latency is established [1]. It is currently believed that the virus 
reactivation is kept in check by host immune cells in the sensory ganglion [4]. The 
psychological and physical stresses that result in temporary impairment of the 
immune system facilitate the reactivation of HSV and subsequent release of the 
virus to the periphery [5].  Most ocular HSV infections result in acute epithelial 
keratitis that can be controlled with several antiviral drugs [6]. Twenty percent of 
the patients infected ocularly with HSV develop, a chronic vision impairing 
stromal lesion known as herpetic stromal keratitis (HSK). In humans, 
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approximately 50% of HSK occurs as a consequence of virus reactivation from the 
trigeminal ganglion and only ~2% of such cases result directly from primary HSV 
infection [1]. The chances of developing SK are three times greater following a 
recurring herpetic keratitis than following a primary infection [1]. 
Symptoms of HSK lesions includes, corneal necrosis and ulceration, 
stromal edema and neovascularization [7]. These lesions are shown to occur 
mainly as a result of T cell mediated immunopathological responses in the cornea 
whose pathogenesis are poorly understood. Forty to ninety percent of the patients 
with stromal keratitis may develop disciform keratitis (corneal endothelium is the 
main site of damage), while the rest of the patients may develop stromal opacities 
[1]. If not treated properly, it may lead to corneal scarring and ulcerations 
warranting corneal transplantation. Apart from stromal keratitis, HSV infection 
could also result in viral retinitis and/or encephalitis in both immunosuppressive 
and immunocompetent individuals [1]. In some cases, infection with HSV-1 or 2 
have also been reported to be associated with the acute retinal necrosis syndrome 
[8]. 
Presently the therapeutic agents used for treating acute keratitis include the 
administration of antivirals and corticosteroids and non-steroidal anti-
inflammatory drugs such as Cyclooxygenase-2 (COX-2) blockers [7, 9, 10]. 
Prolonged use of antivirals was shown to result in the development of resistance 
particularly in immunocompromised individuals [11, 12]. Similarly use of 
corticosteroids might give rise to numerous adverse effects [13, 14] and in some 
patients it may exacerbate HSK lesions due to enhanced HSV-1 replication [15]. 
Animal studies in the mouse model of HSK have demonstrated that cytokine and 
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chemokine blockers such as the IL-1 receptor antagonist are effective [16]. As 
neovascularization is an essential event for HSK pathogenesis, siRNA against 
VEGF was shown to be effective in reducing HSK lesions in the mouse [17]. 
Furthermore, mouse model studies also support the effectiveness of regulatory T 
cell therapy in controlling HSK immunopathology [18]. 
In addition to topical and systemic administration of above mentioned 
drugs, several prophylactic vaccination strategies also are being developed to 
increase the cell mediated protection against HSV. Plasmid DNA encoding viral 
antigens such as gD and /or gB [19-22] and live virus mutants such as vhs-/ICP8- 
HSV strain have been shown to reduce the incidence of HSK [23-25]. They also 
reduced ocular viral shedding and raise the level of neutralizing antibodies in 
infected animals [25]. Subunit vaccines (gB2+gD2) are also shown to be useful in 
controlling recurrent shredding and incidence of HSK in latently infected rabbits 
[26].  Although several clinical trials are being conducted for different HSV 
vaccines, such as gB2/gD2 by Chiron, gD2 MPL by Glaxo SmithKline (GSK) for 
HSV-2, with many more in use, only one therapeutic vaccine for herpes simplex 
keratitis in human has been reported [27]. Effective vaccines against HSV-2 could 
even help reduce the incidence of neonatal ocular herpes. Approaches such as 
intranasal/subconjunctival/topical routes of vaccination [20, 26], addition of 
specific cytokines and chemokines [22, 28] to vaccine or use of an appropriate 
immune modifier like CpG [29, 30] are under investigation to increase the efficacy 
of vaccines against HSV. As the antivirals fail to prevent establishment of latency, 
designing an effective vaccine is important to prevent recurrent ocular diseases. 
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Thus further studies of immune mechanisms involved in the neurological 
surveillance and its use in therapeutic vaccine designing is important.  
MURINE HERPETIC SK MODEL 
Study of the pathogenesis of human HSK from clinical observations, occasional 
biopsy samples and transplant material is difficult. In the earlier literature, most of 
the studies on HSK were performed on rabbits but currently the murine model is 
mostly used to understand SK pathogenesis. Primary ocular HSV infection in mice 
results in a stromal inflammatory response resembling human SK. Several strains 
of mice (BALB/c, CAL-20, 129/SVEV, C57BL/6) and HSV-1 (RE, KOS, McRae 
and F) strain are employed for HSK studies [7]. 
 Primary infection of immunocompetent mice with HSV-1RE results in the 
initial replication of virus in the corneal epithelium for 5-6 days with minimal 
involvement of the stromal or other anterior segment tissues. Viral gene expression 
as judged by mRNA are undetectable after 7-8 days p.i., however, viral DNA 
could be detected in the cornea till day 20 p.i. At this initial replication phase, the 
clinical SK lesions and other signs of inflammation are barely visible. However, 
new blood vessels sprouting from the limbus and histologicaly inflammatory 
events are evident within few hours of infection (Fig .1) (All figures and tables are 
located in the appendices). This early stage of lesion development is usually 
referred to as preclinical phase of SK.  
Inflammatory cells 
Toll-like receptors expressed on innate immune cells form a critical component of 
host surveillance system. Triggering of these pattern recognition receptors 
activates the transcription factor NFκ that causes the induction of cytokines and 
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chemokines in response to the pathogen associated molecular patterns (PAMP) 
[31]. This initial induction of inflammatory genes could lead to the development of 
immunopathological lesions [31]. Components of HSV have been shown to 
possess TLR2 and -9 ligand activity [32, 33]. Human and mice corneas were 
shown to express different functional TLRs and there is accumulating evidence 
that suggests TLRs could be involved in the HSK pathogenesis [34-36]. Virus 
infection in the corneal epithelium, probably by its PAMP activity, initiates several 
humoral and cellular immune responses that together are responsible for clearing 
the infection [31].  As summarized in Fig 1., early inflammatory response that is 
evident in the underlying stroma mainly consisted of the PMNs [37]. This 
infiltration starts as early as 18 hr post infection (p.i.) peaking at around 48 hr and 
then declines by 5 days p.i [37]. This initial pattern of PMN influx correlates with 
the presence of replicating virus and thought to be involved in controlling virus 
spread [37, 38]. Thus, PMN depletion with specific monoclonal antibodies (mAb) 
before infection results in delayed virus clearance from the cornea. Although it is 
not known how the PMNs infiltrating to the stroma could clear the virus from the 
epithelium, however, it has been proposed that TNF-α, nitric oxide and other 
reactive oxygen metabolites could be involved in this process. Degranulation of 
PMNs results in the release of inflammatory mediators such as IL-1β, TNF-α, IL-
12, preformed vascular endothelial growth factor (VEGF) and tissue degrading 
enzyme metalloproteinase-9 (MMP-9) required to break down the stromal matrix 
which are critical to drive the subsequent tissue destructive events that ultimately 
lead to HSK [39-42] (Fig. 2). 
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 Although the early inflammatory phase of ocular HSV infection is 
dominated by PMNs, other cells such as macrophages [43], dendritic cells (DC) 
[44, 45] natural killer (NK) cells [46, 47] and γδ T cells [48] were shown to 
participate in virus clearance and act as a source of cytokines and chemokines in 
the infected cornea [43, 46].  Macrophages also act as a source of angiogenic 
factors VEGF, FGF as well as angiogenic CXC chemokine [49]. In addition to 
these cells, Langerhans DCs also invade the corneal tissues most likely from the 
conjunctiva [44, 45]. Apart from acting as a source of cytokines, their major role is 
to carry the viral antigens to the draining lymph nodes and by which they 
accelerate the immunopathogenesis of HSK by influencing the generation of an 
adaptive immune response. But recent studies in skin infection model question the 
role of Langerhans DCs in antigen presentation and suggest that special subsets of 
migratory DCs could be involved in carrying the viral antigen to the local draining 
lymph nodes [50, 51]. 
Cytokines and Chemokines 
Multiple cytokines and chemokine transcripts are expressed early after HSV 
infection (around 6 hr p.i). Most prominent are IL-1 and IL-6 those are shown to 
be critical to initiate the subsequent cascade of inflammatory events [52, 53]. 
Although after infection, most of the host genes are turned off [54], infected 
epithelial cells can still act as the initial source of IL-1 and IL-6 [55-57]. TLR2 and 
to a lesser extent TLR9 ligand activity of HSV and other endogenous TLR ligands 
could play critical role in initiating this cytokine and chemokine release [35]. 
Accordingly, mice lacking TLR2 and the adapter molecule MyD88 had reduced 
levels of IL-1, IL-6 and MIP-2 in their corneas post infection [35]. Cytokines 
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released from the infected cells as a result of stimulation through PAMPs could 
drive the expression of other key mediators from uninfected cells. Thus, IL-1 can 
trigger IL-6 production from uninfected cells [59] which is known to trigger 
macrophage inflammatory protein (MIP-2) (CXCL8), a critical chemo attractant 
for PMNs [60, 61]. Initial IL-1 production could trigger the upregulation of COX-
2 that could help in the synthesis of proinflammatory prostanoides such as 
prostaglandin E2 (PGE2) [10]. Even TLR ligand activity were shown to be 
involved in the expression of COX-2 in the infiltrating inflammatory cells but it is 
not yet clear whether it is a direct effect or caused by the cytokines released 
through TLR stimulation [35]. Another important cytokine that is upregulated in 
HSV infected cornea is TNF-α [62, 63]. Recent studies show that mice unable to 
produce TNF-α have higher viral titers in the cornea and are more susceptible to 
lesion development [62].  
 In addition to the above list of cytokines, another cytokine that is pivotal 
for the pathogenesis of SK is IL-12, but the trigger for early IL-12 release is yet to 
be identified [64, 65]. The PMNs, macrophages and Langerhans DCs those 
infiltrating into the cornea are the likely sources of IL-12 [40, 66]. One of the 
critical downstream events of IL-12 is the production of IFN-γ from cells like 
macrophage, NK cells and neutrophils that express IL-12 receptor on their surface. 
Previous reports show the role of STAT-4 signaling pathway in the production of 
IFN-γ following IL-12 stimulation [67]. IFN-γ is shown to play several important 
roles in HSK pathogenesis and those include, aiding PMN influx by up regulating 
PECAM-1 (Platelet cell adhesion molecule-1) [68], and upregulation of ICAM-1 
on the corneal epithelium [69], endothelium and keratocytes needed for 
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extravasation of inflammatory cells. It also upregulates MHC-II on antigen 
presenting cells (APCs) those are involved in the induction of pathogenic CD4+ T 
cells in the draining lymph nodes [70, 71]. In addition, IFN-γ was also shown to 
modulate HSK lesions by inducing angiostatic chemokines such as IP-10 
(CXCL10) [72]. 
Another cytokine that has currently received much attention in CD4+ T cell 
mediated immunopathology and autoimmune diseases is IL-17 [73]. IL-17 is 
produced by CD4+ T cells (Th17 cells) and was shown to influence the infiltration 
of PMNs by up regulating IL-6 and IL-8 [74]. Recent studies suggest that IL-17 
could influence the early neutrophil influx into the HSV infected corneas and, 
thus, could have a role in HSK pathogenesis [75]. Recently, the ability of CD4+ T 
cells to produce IL-17 was shown to be regulated by MyD88 dependant TLR 
pathway[76]. This issue needs to be investigated in HSK.  IL-23 that it is essential 
for the maintenance of Th17 cells was shown to be upregulated post ocular HSV 
infection [77]. According to the recent findings, apart from maintaining Th17 
producers, IL-23 could be involved in balancing the production of IL-12 in the 
system. Thus, mice lacking the IL-23 produced more IL-12 and IFN-γ and showed 
heightened susceptibility to HSK [77].  
Apart from the proinflammatory cytokines, HSV infection also induces 
several anti-inflammatory cytokines such as IL-10 and TGF-β in the infected 
corneas. IL-10 was shown to be important in minimizing SK lesion severity. Thus 
mice deficient in IL-10 gene demonstrate a more susceptible phenotype as 
compared to the IL-10 sufficient animals [78]. Additionally, a higher level of IL-
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10 was also observed in the infected corneas during the resolution phage of SK 
[79].   
 Along with several cytokines, ocular infection with HSV also upregulated 
several chemokines such as MIP-2, KC (CXCL3), MCP-1 (CCL-2), RANTES 
(CCL-5), IP-10, MIP-3α (CCL20) [80-82]. These may aid in the influx of 
inflammatory cells into the corneal stroma. Among these MIP-2 and KC were 
shown to be predominant and are critical for the early PMN infiltration [60]. 
Induction stimuli for these chemokines seem to be the proinflammatory cytokines 
released as a result of virus replication in the corneal epithelium. Corneal epithelial 
and stromal cells were shown to produce CCL20 following the stimulation with 
TNF-α and IL-1β [82]. In addition TLR ligand activity of the HSV could also be 
involved in the induction of these chemokines [35]. Another group of chemokines 
expressed in the late preclinical phase are MIP-1α (CCL3) and lymphotactin 
(XCL1) [80]. Although the stimuli for the upregulation of these chemokines are 
not known, these chemokines are pivotal for the infiltration of CD4+ T cells in the 
clinical phase of the HSK lesions.   
Neovascularization  
One of the necessary steps in the immunopathology of HSK is the development of 
new blood vessels post infection in normally avascular corneas [83] as the newly 
formed blood vessels could help in the infiltration of inflammatory cells. New 
blood vessels start sprouting from the limbal vessels by day 1 p.i. reaching the 
central cornea by day 20 p.i. [84]. Inflammatory cells escape from these highly 
permeable blood vessels that result in corneal haze and vision impairment. Ocular 
HSV infection results in the upregulation of several angiogenic factors such as 
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VEGF, bFGF, MMP-9 and E-L-R motif containing chemokines [42, 80, 84, 85]. 
VEGF mediated angiogenesis is a prominent and early event in HSK with VEGF 
transcripts detectable by 12 hr p.i. and protein by 24 hr p.i. [84]. Uninfected 
corneal epithelial cells and stromal cells act as the initial source of VEGF and 
subsequently, it is released by the infiltrating inflammatory cells such as PMNs 
and macrophages [84]. Evidence suggests that proinflammatory cytokines 
generated early after infection such as IL-1 and IL-6 could stimulate the 
production of VEGF [86-88]. Additionally, HSV DNA, rich in CpG motif can 
induce IL-1 and IL-6 with its TLR9 ligand activity that in turn could induce VEGF 
production [89]. Another critical factor involved in the process of 
neovascularization is the collagenase MMP-9 [42]. PMNs and corneal epithelial 
cells are shown to produce MMP-9 in response to inflammatory cytokines such as 
IL-1 and TNF-α [90]. Apart from cytokines, chemokines with E-L-R motifs such 
as MIP-2 are also known to induce ocular angiogenesis [91]. While several 
proinflammatory cytokines and chemokines were shown to induce corneal 
neovascularization, IL-12 and IL-18 are shown to inhibit angiogenesis by 
downregulation of VEGF production [72, 92]. Inhibition of angiogenesis by using 
siRNA against MMP-9 and VEGF were shown to reduce corneal 
neovascularization and HSK lesion severity in a mouse model [17]. Thus, 
modulation of angiogenic factors could prove to be beneficial in the therapy of SK. 
Clinical Stromal Keratitis 
Soon after the early inflammatory events including the clearance of replicating 
virus and viral antigens, around day 6 and 7 p.i., lymphocytes and other 
inflammatory cells infiltrate into the corneal stroma leading to the development of 
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clinically evident SK lesion [93]. Interestingly, although at other inflammatory 
sites, such as TG, higher frequencies of CD8+ T cells are observed but in infected 
corneas CD4+ T cells greatly outnumber the CD8+ T cells [94]. Most of the cells 
infiltrating into cornea express the critical homing marker VLA-4 and chemokine 
receptor CCR5 (MIP-1α [58, 95]. The range of antigens that are recognized by 
these infiltrating CD4+ T cells still remain unknown and the role of viral antigens 
in driving virus specific CD4+ T cells in HSK needs further investigation. 
Interestingly, in TCR transgenic animals with SCID/ RAG background that could 
not recognize viral antigens, it is possible to induce lesions with a replication 
competent virus [96, 97]. These observations suggest that probably the 
inflammatory events following HSV infection could result in unmasking of the 
corneal autoantigens [2]. Few other observations also suggest that virus specific 
CD4+ T cells may crossreact with corneal antigens and could contribute to HSK 
pathogenesis. Support for this hypothesis comes from Cantor’s lab where they 
showed that the UL-6 protein from HSV acts as a molecular mimic for a corneal 
autopeptide [98]. The role of molecular mimicry still needs further confirmation. 
Alternately, bystander activation of T cells in a non TCR mediated manner by the 
inflammatory molecules produced as a result of ocular HSV infection could 
explain HSK pathogenesis. Although not explained mechanistically, the 
observation that it is possible to induce SK in the mouse whose T cells are 
genetically incapable of recognizing viral antigen could support the involvement 
of bystander mechanisms [99, 100]. In this system cells dying of HSV infection 
were responsible for inducing cytokine production [100, 101].  
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 Another subset of T lymphocytes that infiltrate the cornea is the 
CD4+CD25+Foxp3+ Treg cells.  In addition to other mechanisms such as the 
cytokine IL-10 [102], Treg are shown to be involved in controlling the ongoing 
inflammatory processes in the cornea [95]. In addition, these cells might help in 
the resolution of the clinical lesions. Studies suggest that depletion of Treg from 
the mice prior to infection results in more severe SK lesions [95]. Different 
mechanisms involved in the suppressive activity of Treg are release of cytokines 
IL-10, IL-35 and TGF-β, direct contact with effectors and APCs etc. [102, 103], 
but the mechanism and the site of Treg activity in HSK is controversial and need 
further investigations. The fact that even in IL-10-/- animals have functional Tregs 
and that depletion of Tregs in IL-10-/- animals could increase the lesion severity 
suggests that Tregs and IL-10 are two independent anti-inflammatory mechanisms 
in HSK [104]. 
CONCLUSION 
Currently several therapeutic and prophylactic drugs are being used for the 
treatment of SK.  Discovery of new molecular participants in the pathogenesis of 
SK will show new targets for designing better therapeutic drugs. Study in mouse 
model shows a role of TLR2 and TLR9 signaling in HSK. Even in human HSK 
corneas, changes in the expression levels of several TLRs are being noticed [35, 
36].  What is not yet known is under physiological condition how such a small 
amount of virus could trigger the TLRs. Better understanding of the signaling 
processes, induction of critical inflammatory molecules and their appropriate 
modulation could help in finding cure for SK. Similarly, anti-inflammatory 
mechanisms such as induction of IL-10 and regulatory T cell could be beneficial in 
 13
the prevention as well as resolution of SK lesions. Therefore, several drugs and 
reagents such as FTY720, retinoic acid, galactin-9 [105-107] those are capable of 
inducing regulatory T cells or IL-10 could be useful therapeutic strategies to 
suppress SK lesion severity.  These approaches could be used as single or in 
combination with other existing therapies for better result and less side effect. 
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Figure. 1. Principal events in herpetic SK pathogenesis 
Following ocular HSV infection replicating virus could be detected in the cornea 
till 5-7 days p.i. Early inflammatory response in the cornea is dominated by the 
polymorphonuclear leukocytes (PMN). Infiltration of PMNs into the cornea is be 
characterized by a typical biphasic influx.  Angiogenesis or the process of new 
blood vessel development from the existing limbal vessels starts at 24h p.i. and 
peaks around 15 days p.i.  Influx of pathogenic CD4+ T lymphocytes occurs in the 
clinical phase around 7-9 days p.i. 
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Figure. 2 Schematic representation of the early events in the SK cornea 
HSV-1 with its TLR 2 and TLR9 ligand activity induces numerous 
proinflammatory cytokine and chemokines early after infection of corneal 
epithelium. These cytokines and chemokines in turn help in the influx of 
inflammatory cells such as PMNs, macrophages, NK cells and dendritic cells into 
the infected corneas.   Presence of inflammatory cells and the production of more 
inflammatory mediators and the angiogenic factors help in creating favorable 
conditions for the subsequent events that lead to the clinical phase. Development 
of new blood vessels from the exiting limbal vessels also helps in the influx of 
inflammatory cells into the corneal stroma in the clinical phase of SK.  
 33
  
 
 
 
 
Part-II 
Innate recognition network driving the HSV 
induced corneal immunopathology: role of toll 
pathway in the early inflammatory events in 
stromal keratitis 
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Research described in this chapter is a modified version of an article published in 
2007 in The Journal of Virology by Pranita P Sarangi, Bumseok Kim, Evelyn 
Kurt-Jones and Barry T Rouse. 
 
Sarangi PP, Kim B., Kurt-Jones E, Rouse BT. Innate recognition network driving 
the HSV induced corneal immunopathology: Role of Toll Pathway in the early 
inflammatory events in Stromal Keratitis. J Virol. 2007. Oct; 81(20):11128-3.  
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In this chapter “our” and “we” refers to me and co-authors. My contribution in the 
paper includes (1) Selection of the topic (2) Compiling and interpretation of the 
literature (3) Designing experiments (4) understanding the literature and 
interpretation of the results (5) providing comprehensible structure to the paper (6) 
Preparation of graphs, figures and tables (7) Writing and editing 
Abstract 
Ocular infection with herpes simplex virus (HSV) sets off an array of 
events that succeed in clearing virus from the cornea but leaves the tissue with a 
CD4+ T cell orchestrated chronic inflammatory lesion that impairs vision. We 
demonstrate that Toll-like receptor (TLR) signaling forms a part of the recognition 
system that induces the syndrome that eventually culminates in immunopathology. 
Accordingly, in a comparison of the outcome of the infection in wild-type (WT) 
mice and those lacking TLR function it was apparent that the absence of TLR2, 
and to a lesser extent TLR9, resulted in significantly diminished lesions. Similarly 
mice lacking the adapter molecule MyD88 were resistant to lesion development 
but such animals were also unable to control infection with most succumbing to 
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lethal encephalitis. The susceptibility of TLR4-/- animals was also evaluated. 
These animals developed lesions more rapidly that were more severe than in WT 
animals. We discuss the possible mechanisms by which early recognition of HSV 
constituents impact on the subsequent development of immunopathological 
lesions. 
Introduction 
Viruses induce several immediate host reactive events that impact on the 
long term consequences of infection. For example, ocular infection of mice with 
herpes simplex virus (HSV) causes a multitude of cytokine, chemokine and 
cellular changes to occur [1]. Manipulating the expression of many of these affects 
the severity of the subsequent vision impairing consequences such as 
neovascularization and chronic inflammation [2-5]. The latter reaction is 
immunopathological set off initially by infection, but sustained well after 
replication has ceased and viral antigens are removed [1]. These stromal keratitis 
(SK) reactions occur in response to HSV in humans and represent the commonest 
cause of infectious blindness in developed countries [6].  
We know that viruses and their components can trigger multiple innate 
immune protective and inflammatory responses [7]. These include interferon 
induction, the production of multiple cytokines, and activation of complement as 
well as innate cellular defenses [7, 8]. Recognition mechanisms that initiate and 
control innate reactions to viruses remain poorly understood but accumulating 
evidence indicates that membrane bound cell surface or intracellular toll-like 
receptors (TLRs) form part of the surveillance system [9]. After the initial 
observation with respiratory syncytial virus [10], several viruses were shown to 
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express ligand activities for one or more TLRs [9]. Infection could also result in 
the release and induction of host molecules such as heat shock proteins that may 
themselves activate TLRs and so contribute to the innate response [11, 12]. The 
observation that TLRs participate during HSV infection came from several lines of 
investigation. Initially purified HSV DNA like synthetic CpG DNA, the ligand for 
TLR9 [13], was shown to induce ocular neovascularization, an essential step in the 
pathogenesis of SK [14]. HSV DNA was later confirmed to possess TLR9 ligand 
activity [15] and studies in knockout mice revealed a role for TLR9 in HSV 
induced type I interferon production [13]. Other investigations demonstrated that 
HSV also possesses TLR2 activity [16] with mice lacking TLR2 showing higher 
resistance to lethal HSV encephalitis than WT animals [16]. This perhaps 
unexpected observation that brain inflammation and death were reduced in the 
absence of TLR2 (but virus levels were similar in WT and TLR2-/- mice) 
indicated that encephalitis, the usual cause of death with HSV infection, was the 
consequence of the virus acting as a TLR2 ligand driving an inflammatory reaction 
in the brain [16].  In addition to inflammatory processes, herpetic encephalitis, 
especially in humans may represent a direct destructive effect of the virus [17] and 
even in mice neurovirulence appears associated with the success of virus gaining 
access to and replicating in the CNS [18].  Thus both viral and host components 
may contribute to disease pathogenesis. 
In the present report, we measured the influence of TLR2 and other 
potential TLR ligand effects of HSV in a corneal scarification disease model 
where lesion expression is widely agreed to represent a host immunopathological 
response [1]. In this model, animals lacking lymphocytes fail to develop SK 
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lesions and in fact die of herpetic encephalitis with an abundance of virus in the 
brain [19]. We examined the sequence of events that occurred following infection 
of different TLR knockout mice compared to WT animals. Our results demonstrate 
that TLR2-/-, MyD88-/- and to a lesser extent TLR9-/-, but not TLR4-/-, mice 
showed significantly reduced SK lesions upon HSV infection. Similarly, TLR2-/- 
and MyD88-/- mice also showed reduced neovascularization as compared to other 
groups. These latter strains also showed marked reduction in early non lymphoid 
inflammatory infiltrates as well as lower levels of proinflammatory cytokines 
compared to WT or TLR4-/- animals. In addition, whereas both TLR2-/- and 
TLR9-/- animals resisted the lethal effects of HSV, most MyD88-/- animals 
infected with the same dose succumbed to lethal disease. The TLR4-/- animals 
developed lesions more rapidly that were more sever than in WT animals. We 
discuss the possible mechanisms by which early recognition of HSV constituents 
impacts on the subsequent development of immunopathological lesions. 
Materials and methods 
Animals. 
TLR2-/- ,TLR4-/-, TLR9-/-, TLR2/4d-/-, MyD88-/-   mice were the kind gift of Dr 
S Akira, (Osaka University, Osaka) and were backbred for more than 10 
generations onto the C57BL/6 background. Backbreeding was confirmed by 
examining a 110 marker panel that distinguishes between C57BL/6 and 129 
(Charles River Laboratories). These microsattelite markers are spread across the 
19 autosomes and the X chromosome at approximately 15cM intervals. C57BL/6 
mice were obtained from Harlan Sprague-Dawley, (Indianapolis IN). All 
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experimental procedures followed the guidelines the Association for Research in 
Vision and Ophthalmology resolution on the use of animals in research.  
Corneal HSV-1 infection and clinical observation 
 HSV-1 strain RE was used in all procedures. Details of corneal infections of mice 
under deep anesthesia were described in a previous publication [20]. Animals were 
infected with a range of virus doses although most of the reported experiments 
mice were infected with 5×103 pfu/eye. The experiments were repeated multiple 
times especially the comparison of TLR2-/- with control animals. Lesion scores 
and the extent of angiogenesis were measured at various times post infection as 
described in detail previously [21, 22].  
Histopathology 
For histopathologic analysis, eyes from different groups of mice were extirpated at 
the indicated time point p.i. and snap-frozen in OCT compound (Miles, Elkart, 
IN). Six micron thick sections were cut and air dried in a desiccation box. Staining 
was performed with hematoxylin and eosin (Richard Allen Scientific, Kalamazoo, 
MI). 
Flow Cytometry. 
For flow cytometry measurement of the infiltrating cells, four corneas or two 
trigeminal ganglias (TGs) were collected per time point. Corneas or TGs were 
digested in liberase (Roche Diagnostics Co., Indianapolis, IN) for 45 min at 37oC. 
Single cell suspension was prepared as described elsewhere [23]. The Fc receptors 
were blocked with unconjugated anti CD16/32 (BD Pharmingen, San Diego, CA) 
for 30 min. Samples were incubated with fluorescein isothiocyanate (FITC) 
labeled anti Gr-1, anti CD11b, anti CD11c (BD Pharmingen), F4/80 (eBioscience), 
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or anti CD4 (BD Pharmingen), antibody for 30 min. For intracellular staining for 
(Cyclooxygenase-2) COX-2, goat anti COX-2 and Donkey anti goat IgG were 
used as primary and secondary antibody (Santa Cruz Biotechnology, Santa Cruz, 
CA) respectively. For detection of induced Hsp-70, FITC conjugated Hsp70 
(Hsp72) antibody was obtained from Stressgen (Ann Arbor, Michigan). FITC 
conjugated Rat IgG was used as isotype control for Hsp-70. Intracellular staining 
for COX-2 and Hsp70 was performed using Fixation/Permeabilization Solution 
Kit with BD GolgiPlug (BD Bioscience). All samples were collected on a 
FACScan (BD Biosciences, San Diego, CA), and data were analyzed by using cell 
Quest 3.1 software (BD Biosciences). 
Cytokine and chemokine ELISA of corneal lysate 
For preparation of corneal lysates, six corneas per indicated time point were 
pooled from each group of mice and were processed as described previously [20]. 
For draining lymph nodes (DLNs), cervical lymph nodes from each mouse were 
collected and processed. Levels of IL-6, IL-1β, Macrophage Inflammatory Protein-
2 (MIP-2) and Vascular Endothelial Growth Factor (VEGF), IL-10 in corneal 
lysates and IL-10, IL-6, IFN-γ in DLN lysates were determined by a standard 
sandwich enzyme-linked immunosorbent assay (ELISA) protocol. Anti IL-6, anti 
IL-10, anti IFN-γ capture and detection antibodies were purchased from BD 
Pharmingen. Anti IL-1β, anti-MIP-2, anti VEGF capture and biotinylated detection 
antibodies were purchased from R&D Systems (Minneapolis, MN). The color 
reaction was developed using ABTS (Sigma-Aldrich, St. Louis, MO) and 
measured with an ELISA reader (Spectramax 340; Molecular Devices, Sunnyvale, 
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CA) at 405 nm. Quantification was performed with Spectramax ELISA reader 
software version 1.2.  
Reverse Transcription and real time PCR 
Total RNA from naïve and infected C57BL/6  corneas and DC2.4 cell line were 
isolated at different days p.i. by using RNAeasy kit (QIAGEN, RNeasy MinElute 
Cleanup Kit) and was reverse transcribed by using Murine Leukemia Virus reverse 
transcriptase (Life Technologies, Bethesda, MD) with oligo (dT) as the primer 
(Invitrogen, San Diego, CA). All cDNA were divided into aliquots and stored at -
20oC until further use. All murine DCs express TLR2, 4 and 9 as did the DC2.4 
cell line (Dendritic cell line, obtained from Dr K.L. Rock). PCR was performed in 
a PTC-100 programmable thermal controller (MJ Research, Cambridge, MA) 
using Hot start PCR Master mix (Promega, Madison, WI). The primers used were 
murine GAPDH forward (CATCCTGCACCACCAACTGCTTAG) and reverse 
(GCCTGCTTCACCACCTTCTTGATG), murine TLR2 forward 
(AAGAGGAAGCCCAAGAAAGC) and reverse 
(CGATGGAATCGATGATGTTG), murine TLR4 forward 
(ACCTGGCTGGTTTACACGTC) and reverse 
(CTGCCAGAGACATTGCAGAA), murine TLR9 forward 
(ACTGAGCACCCCTGCTTCTA) and reverse 
(AGATTAGTCAGCGGCAGGAA). 
Real-time PCR was performed using an iQ5 Real-Time PCR Detection 
System (Bio-Rad). PCR was performed using SYBR Green PCR Master Mix 
(Applied Biosystems), according to manufacturer’s protocol. PCR amplification of 
housekeeping gene, murine HPRT, was done for each sample as a control for 
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sample loading and to allow normalization between samples.  The primers used 
were murine HPRT forward (GACCGGTCCCGTCATGC) and reverse 
(TCATAACCTGGTTCATCATCGC), murine β-defensin 2 (mBD-2) forward 
(TATGCTGCCTCCTTTTCTCA) and reverse (GACTTCCATGTGCTTCCTTC), 
murine β-defensin 3 (mBD-3) forward (CTCCTGGTGCTGCTGTCTCCAC) and 
reverse (AACTCCACAACTGCCAATCTGA).  
Virus recovery and titrations 
Eye swabs were taken from infected corneas (four eyes/group) using sterile swabs 
at the indicated time points. Similarly, brain tissue and TG were taken out from the 
infected animals at the indicated time points (N=3). The tissues were disrupted by 
homogenization in 1 ml ground glass grinders (Wheaton) and centrifuged, and the 
supernatant was used to assay viral titers. and was the titration was performed by 
standard plaque assay as described previously [20].Titers were calculated as log10 
pfu/ml as per standard protocol [24]. 
Statistical Analysis 
Statistical significance was determined by Student's t test. P < 0.05 was regarded 
as a significant difference between the groups. 
Results 
Expression of TLRs and TLR ligands in the naive and infected corneas 
Since HSV replication in the eye occurs almost exclusively in corneal 
epithelial cells  [1], the expression of TLRs in corneal buttons taken from 
uninfected eyes was examined by RT-PCR for the presence of TLR2, 4 and 9 
mRNA. All could be demonstrated (Fig.1A). Whereas previous reports had shown 
that both TLR2 and TLR9 activating ligands are expressed by HSV [25], 
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endogenous TLR ligands might also be induced and released from dead or dying 
cells following infection [11, 12]. As shown in Fig1B, the TLR4 ligand, inducible 
Hsp70 [11] could be demonstrated in corneal tissues in samples analyzed at 24 h 
post HSV infection. Similarly, as shown in Fig1C, both β-defensin2 and β-
defensin3 mRNA expression was increased in the infected as compared to the 
naïve corneas of which and β-defensin3 has been shown to trigger TLR4 [26]. 
Hence TLR4 as well as previously demonstrated TLR2 and TLR9 ligand effects 
could be involved in the recognition events following ocular HSV infection.  
Disease expression following HSV infection in control and knockout mice 
To determine the role of TLRs in HSV pathogenesis in the eye, TLR 
knockout mice that were fully backbred onto the C57BL/6 background were 
ocularly infected with different doses of HSV-1 RE and evaluated over a 15-20 
day time period to quantify the extent of corneal neovascularization as well as the 
severity of SK. At infection doses of 2 × 105 pfu/eye or above all groups 
developed lesions and neovascularization responses that were similar in 
magnitude. However, significantly different responses in the various groups 
became evident at infection doses of 2 × 104 and below. Fig. 2 shows the results of 
1 of 2 experiments in which the animals were infected with 5 × 103 pfu virus. As is 
evident, at both days 8 and 15 p.i., both the TLR2-/- and MyD88-/- animals 
showed significantly diminished lesions as well as neovascularization compared to 
WT animals. For instance, where as almost 90% of control WT animals developed 
SK lesions with a severity score of 3 or greater and neovascularization scores of 8 
or greater, in TLR2-/- and MyD88-/- animals only around 30% of animals had 
such severity scores. Moreover at the peak response time (day15 p.i.) the mean 
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severity scores in TLR2-/- and MyD88-/- were 1.5 ± 0.37 and 1.8 ± 0.4 
respectively which were significantly (p ≤ 0.005) less than those observed in WT 
mice (3.8 ± 0.26). On average the mean severity of SK in TLR2-/- was 60% 
reduced over controls at day 8 p.i. and was further reduced to 65% by day 15 p.i. 
These experiments indicate that animals unable to respond to the TLR2 ligand 
activity of HSV showed a resistant phenotype. However curiously, both TLR2-/- 
and MyD88-/- animals often showed quite severe herpetic periocular disease, a 
lesion seldom seen in the WT animals at the low dose of virus used.  
Animals lacking TLR9 also showed more resistance to HSV induced SK 
and neovscularization than WT animals although differences were modest and 
only significantly reduced with the 15 day scores (2.7 ± 0.38 compared to 3.8 ± 
0.26, p=0.03) (Fig. 2). Most of the TLR9-/- animals also developed herpetic 
periocular disease but lesions were less intense than those noted in TLR2-/- and 
MyD88-/- animals.  
The pattern of response in TLR4-/- animals revealed a modestly more 
susceptible phenotype. Thus by day 8 p.i., 30% of TLR4-/- showed level 3 lesions 
(mean, 2.3 ± 0.13) whereas almost all WT animals lacked lesions at this time point 
(mean, 1.2 ± 0.15, p = 0.004). The neovascularization score reflected a similar 
heightened susceptibility of TLR4-/- (mean, 7 ± 0.5) compared to WT animals 
(mean, 4.5 ± 0.4, p =0.009) (Fig. 2). Curiously, animals lacking both TLR2 and 4 
responsiveness showed a resistance phenotype although this was less in magnitude 
compared to TLR2 or MyD88 knockout animals.  
MyD88 is an essential downstream adapter of TLR signaling, particularly 
for TLR2 and TLR9 responses [27].  TLR4 also signals via MyD88 but can 
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activate an alternate pathway of MyD88-independent gene expression [28].  
Interestingly, although the MyD88-/- animals showed a resistant phenotype to 
disease expression similar to the TLR2-/- mice, the MyD88-/- animals were far 
more susceptible to the lethal effects of HSV infection. As shown in table. 1, even 
at the 5 ×103 pfu dose, up to 70 % of the infected MyD88-/- animals were dying by 
day15 p.i. although almost 60 % of them showed no signs of clinical disease. The 
animals were presumed to be dying from viral encephalitis and replicating virus 
could be demonstrated in the homogenates of brain tissue harvested from 
moribund MyD88-/- animals (Table. 2). Thus, eliminating signaling through 
multiple TLRs by knocking out MyD88 reduces local inflammation but may allow 
enhanced viral replication and/or spread, while eliminating single TLRs, i.e., 
TLR2 or TLR9, ameliorates local immune pathology but these receptors may be 
redundant for control of virus replication/spread. 
  As shown in table. 1, both at 2 ×104 pfu/eye and 5 ×103 pfu/eye of 
infection, neither TLR2-/- nor TLR9-/- animals were more susceptible to lethal 
infection as were WT animals.  In addition to brain and TGs, virus titers were also 
measured in eye swabs collected from infected cornea. As shown in table3, in 
contrast to CNS, virus titers did not increase in the absence of TLRs or MyD88-/- 
in the corneas and all of the groups could clear the virus efficiently by day7 p.i. 
Our data confirms the previous finding by others that  MyD88 independent  
antiviral mechanisms can effectively compensate for the absence of MyD88 in a 
localized HSV-1 infection [13] 
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Cellular differences between control and knock out animals 
 Soon after HSV infection of the corneal epithelium, cytokine expression 
and cellular changes occur [1]. One prominent event is infiltration in the 
underlying stroma by mainly neutrophils [29]. The stimuli that induce such 
responses remain to be identified but they appear to include chemokines such as 
MIP-2 and MCP-1 induced directly or indirectly by HSV infection in the corneal 
epithelium [1, 30]. Additionally, angiogenic molecules such as VEGF and IL-6 are 
induced both of which play a role at causing the neovascularization of the cornea 
[20, 31]. To compare the initial inflammatory response in knockout versus WT 
control mice, tissue sections were examined. As is evident in Fig. 3, diminished 
cell infiltrates at 48 h were apparent in TLR2-/- , MyD88-/- as well as in TLR9-/- 
sections compared to WT controls. In the latters the inflammatory infiltrates had 
fully accessed the central cornea, but in both TLR2-/- and TLR9-/- the infiltrates 
were largely confined to the limbal region. Of these two TLR knockouts, the 
infiltration of cells in TLR2-/- was far less than in TLR9-/- animals. Of interest, 
the inflammatory events in TLR4-/- animals appeared slightly elevated as 
compared to WT. This more severe reaction was also more evident by flow 
cytometric analysis of Gr1+ and CD11b+ cells in the infected corneas (Fig. 3). 
It has been documented by past studies that after ocular infection with 
HSV, replicating virus could be detected in the TG for 2-7 days p.i. [32]. The 
presence of virus in the TG induces a chronic inflammatory reaction involving 
multiple cell types that is responsible for controlling the virus load as well as to 
restricting the further spread of the virus [32]. Therefore, we examined the cells 
from the TG of different groups at 48 h and 96 h p.i. by flow cytometry.  A 
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diminished inflammatory lesion was observed in the infected TGs in the TLR2-/- 
and MyD88-/- as compared to wild type. As shown in Fig. 4, infiltration of Gr1+, 
CD11b+, CD11c+ and F4/80+ cells was reduced in the TLR2-/- and MyD88-/- 
animals. Interestingly, similar to the cornea, an increased inflammatory cell 
number was noticed in the TLR4-/- animals as compared to WT controls. 
Cytokine and other proinflammatory protein differences between control and 
knock out animals 
A likely explanation for the reduced influx of inflammatory cells and 
eventual resistance to disease expression in TLR2-/- (and MyD88-/-) mice could 
be a reduced proinflammatory cytokine/chemokine response to infection. Lysates 
of corneas collected at 48 h and 96 h p.i. were used to measure the levels of 
candidate molecules shown in previous studies to correlate with the outcome of 
ocular HSV infection [1]. These were IL-6, MIP-2, and IL-1β, VEGF as well as 
the enzyme COX-2.  As shown in Fig. 5, compared to WT, a three- to four-fold 
reduction in the levels of these proinflamatory mediators was evident in the lysates 
of TLR2-/- and MyD88-/- corneas at 48 h and 96 h p.i. IL-6 and IL-1β, produced 
from virus infected cells were shown to stimulate noninfected resident corneal 
cells and other inflammatory cells in a paracrine manner to secrete VEGF, a potent 
angiogenic factor [1]. Interestingly, a marked reduction was noticed in the level of 
IL-1β and IL-6 and VEGF in the TLR2-/-, MyD88-/- mice. The TLR9-/- animals 
had a moderate decrease in inflammatory mediators but this was only evident at 
the 48 h time point. In contrast, TLR4-/- animals had slightly increased levels (20-
30 % elevated) of inflammatory mediators as compared to the WT controls at all 
time points examined. 
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 In two separate experiments the level of IL-10 induction in TLR4-/- mice 
was compared to WT animals in both corneal extracts and the cervical DLN at 
day2 and day5 after infection. As is evident in Fig. 6A, levels of IL-10 in the 
corneas of TLR4-/- mice were less than observed in WT animals at both time 
points accounting perhaps for the more severe reactions seen in TLR4-/- animals. 
Although significant differences were not observed in the levels of IL-10 in DLN 
at these time points (Fig. 6B), the levels of proinflammatory and Th1 cytokine, IL-
6 and IFN-γ were significantly higher (p ≤ 0.05) in TLR4-/- animals as compared 
to WT (Fig. 6C and D). Interestingly, no difference was observed in the IL-10 
levels in the DLNs of TLR-2-/- animals although the levels of IL-6 and IFN- γ 
were lower in TLR2-/- as compared to WT animals (data not shown).  
  Previous studies had showed that, HSV infection of the cornea 
upregulates the expression of COX-2, a critical enzyme for the induction of 
potential inflammatory mediators such as prostaglandins [33, 34]. Moreover, the 
administration of a selective COX-2 inhibitor diminished virus induced SK lesions 
and neovascularization [35]. Recent in vitro findings had demonstrated that TLR2 
signaling could induce COX-2 in peritoneal macrophages in vitro [36-38].  
Therefore, we examined the role of TLR2 in HSV induced COX-2.  Intracellular 
staining revealed over 50% reduction in the percentage of COX-2 expressing cells 
in HSV infected TLR2-/- mice corneas as compared to the WT and TLR4-/- mice 
(Fig. 7A). In addition, reduced numbers of COX-2+Gr1+ cells was evident in the 
TLR2-/- corneas as compared to WT (Fig. 7B). Interestingly, although there was 
no difference in the percentage of COX-2 expressing cells in TLR4-/- animals as 
compared to WT, such animals  showed higher proportion of COX-2+Gr1+ cells as 
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compared to WT animals (Fig. 7A and B). These results may mean that lower 
induction of prostaglandins as well as chemokines could be a possible explanation 
of the resistant and susceptible phenotype in TLR2-/- and TLR4-/- mice 
respectively.  
Discussion 
Ocular infection with herpes simplex virus sets off an array of events that 
succeed in clearing virus from the cornea but leaves the tissue with a CD4+ T cell 
orchestrated chronic inflammatory lesion that impairs vision. We demonstrate that 
TLR signaling forms a part of the recognition system that sets off a syndrome that 
eventually culminates in immunopathology. Accordingly, in a comparison of the 
outcome of the infection in WT mice and those lacking TLR function it was 
apparent that the absence of TLR2, and to a lesser extent TLR9, resulted in 
significantly diminished lesions. Similarly, mice lacking the adapter molecule 
MyD88 were resistant to lesion development but such animals were also unable to 
control infection and most succumbed to lethal encephalitis. Animals lacking 
TLR4 developed lesions more rapidly and these became more severe than in WT 
animals. It could be that modulating TLRs in an appropriate way could represent 
an approach to control the severity of SK, an important cause of vision 
impairment.  
Past studies had demonstrated that HSV expresses at least 2 TLR ligand 
activities [16]. These were for TLR2, perhaps a property of one of the envelope 
major glycoproteins [25], and the TLR9 ligand activity of its DNA [15]. In this 
report, we also show that HSV infection can cause cells to endogenously express 
at least two molecules that act as TLR ligands. These were BD3, a TLR4 ligand 
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[26], and inducible Hsp70 ligand for TLR4 and perhaps also for TLR2 [11]. Our 
investigations were designed to determine if the absence of TLR2, 4 and 9 
impacted on the outcome of an immunopathological reaction in the eye that results 
from HSV infection.  
The most dramatic effects were observed when TLR2-/- mice were 
infected with a low dose of a virulent strain of HSV. Compared to WT animals, 
TLR2-/- mice showed considerable resistance to disease expression. Fewer eyes 
showed clinical lesions, and those that did had reduced levels of 
neovascularization and stromal inflammatory reactions at both the early and peak 
times of the response. Reduced inflammatory reactions were also evident in the 
trigeminal ganglion, a site where virus locates soon after ocular infection and 
where virus persists when acute infection resolves [1]. Curiously, however, TLR2-
/- animals usually expressed notable periocular disease even when the eye itself 
exhibited minimal or no lesions. We interpret these data to mean that the TLR2 
ligand activity of HSV may be a major mechanism by which the virus, usually 
confined to the epithelium of the infected cornea [1], induces early events 
necessary for the development of the inflammatory disease. As shown in previous 
studies, these include cytokines such as IL-6 and IL-1β and TNF-α [1], the 
chemokine MIP-1α, MIP-2 [1], enzymes such as COX-2 associated with the 
production of inflammatory molecules [1] and molecules responsible for 
neovascularization of the usually avascular eye such as VEGF and MMP9 [1]. In 
line with this, when levels of some of these molecules were measured early after 
infection, all were reduced in amount in TLR2-/- compared to WT eyes. Evidence 
that cells from TLR2 negative cells make reduced inflammatory cytokine 
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responses to HSV was previously reported by others [16, 39]. Moreover, such 
reduced inflammatory reactions in the brain to HSV were advocated to explain 
why TLR2-/- mice were less susceptible to HSV encephalitis than were WT 
controls [16]. Similarly in SK, the resistance phenotype of TLR2-/- animals is 
likely explained by the reduced induction of key inflammatory mediators. 
 The observation that periocular disease was more severe in TLR2-/- mice 
was less easy to explain especially since viral clearance kinetics in the eye itself 
between TLR2-/- and WT showed no significant differences. Similarly, in the 
brain, Kurt-Jones et al, observed no major differences in viral clearance between 
control and resistant TLR2-/-animals [16]. Since the periocular lesions appear to 
be caused by the virus itself, rather than being an immunopathological reaction, 
conceivably the diminished stimulation of local antiviral molecules such as 
interferons and perhaps others involved in the acute inflammatory response may 
explain the outcome in TLR2-/- mice. We are further evaluating this issue. 
 Since HSV DNA is well known to act as a TLR9 ligand [13, 15], we 
anticipated that TLR9-/- mice would also react differently to the ocular infection 
than WT animals. Such TLR9-/- mice were in fact more refractory to lesion 
expression than WT, but this was only a modest difference. This may be explained 
by the possibility that the TLR9 ligand activity is inadequately produced under in 
vivo infection conditions to drive the neovascular and inflammatory response, or 
that any effect of TLR9 is largely overridden by the proinflammatory effect of the 
TLR2 ligand activity of the virus. We hope to obtain double knockout mice to help 
resolve these issues. Alternately, there could be reduced Th1 immune response in 
the absence of TLR9 which could help reduce the lesion severity. We are currently 
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investigating the generation of HSV specific immune responses in the absence of 
specific TLRs.  
 Previous studies on herpetic encephalitis had not revealed a response 
pattern phenotype for TLR4-/- animals. However, following ocular infection, such 
animals were significantly, although not dramatically, more susceptible both to 
neovascularization and SK lesion development. Lesions also occurred earlier than 
in WT animals and a higher percentage of infected eyes developed lesions. 
Periocular disease, however, was unusual as it is in WT animals. Although 
currently we lack a definitive mechanistic explanation for these observations, 
several ideas are being pursued. These include the possibility that the TLR4 ligand 
activities might serve to either induce the production of anti-inflammatory 
cytokines [40], or the induction of some type of regulatory T cell response [41], or 
that the enhanced reactions occurred because of a heightened anti-HSV immune 
response in TLR4-/- animals. Currently, we have preliminary support for at least 
two of these ideas. Thus IL-10 levels in corneal extracts of TLR4-/- mice were less 
than those present in WT control extracts (Fig. 6). Additionally, the magnitude of 
T cell responses in TLR4-/- animal was marginally elevated over that of WT 
animals (data not shown). We have yet to evaluate any differential induction of 
regulatory T cell responses between TLR4-/- and control animals but such studies 
are underway. 
 Our studies also included minimal investigations on the outcome of 
infection in animals lacking both TLR2 and TLR4. Such animals also showed the 
resistance phenotype but the magnitude was less than observed in TLR2-/- and 
MyD88-/- animals. This could mean that the TLR2 ligand effect of the HSV is the 
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dominant activity but this is partially blunted by the apparent anti-inflammatory 
effect of TLR4 ligand stimulation. Perhaps the use of TLR4 ligands have some 
place in the future therapy of SK. 
 Finally, our studies evaluated HSV induced ocular responses in MyD88-/- 
mice. Such animals showed approximately the same phenotype as did the TLR2-/- 
mice which may mean that TLR2 ligand mediated effects are the most significant 
proinflammatory agonists with HSV infections. MyD88-/- mice, however, showed 
one major response difference compared to TLR2-/- and other TLR-/- animals. 
This was their marked susceptibility to herpetic encephalitis with animals usually 
dying by 15 days p.i. Others have also observed that HSV may prove lethal to 
MyD88-/- animals infected intranasaly [42]. The explanation for this heightened 
susceptibility to encephalitis remains unclear. Accordingly, although virus was 
cleared normally in MyD88-/- mice from the eye and TG, this was not true for the 
brain where it persisted and was still present in dying animals. We anticipate that 
the susceptibility of MyD88-/- animals might be explained by a deficiency in some 
critical innate and/or adaptive immune responses that functions in the CNS. In 
some other infection systems too MyD88-/- animals show reduced ability to 
generate an effective adaptive immune response [43]. In our preliminary studies 
we have noted that the antigen presenting cell function in MyD88-/- mice are 
impaired which might have an effect on the generation of an effective immune 
response. 
 In conclusion, our results indicate that the TLR ligand activity of HSV, 
primarily TLR2, plays a role in the induction of an immunopathological response 
in the cornea and TG. Other TLR ligands, such as TLR4, may serve to counteract 
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the severity of the inflammatory response. It is conceivable that manipulation of 
the TLR ligand response could provide a means to modulate SK lesions.  
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APPENDIX 
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Figure 1. Induced TLR ligands in the HSV infected corneas  
A. Corneal buttons from uninfected mice were harvested and isolated total 
mRNA was tested by RT-PCR for TLR2 and TLR4 and TLR9. All three 
could be demonstrated in the naïve cornea. The DC2.4 cell line was used as 
positive control.  
B. Single-cell suspension of corneal cells was prepared from four corneas at 
24 h p.i. Intracellular staining was done with FITC-labeled anti Hsp70 
antibody as mentioned in the material and methods. The number of Hsp70 
expressing cells was determined by FACS. Rat IgG was used as the isotype 
control. The number on the upper-right corner represents the percentage of 
Hsp70 cells/1×105 corneal cells at 24 h p.i. 
C. C57BL/6 mice were infected with 2 × 104 pfu of HSV-1RE. At the 
indicated time points, four corneas from infected mice were collected and 
total mRNA was extracted. Real time PCR was performed to compare the 
expression of mouse β-defensin-2 (mBD2) and mouse β-defensin-3 (mBD-
3) mRNA in the infected corneas at different time point p.i. as described in 
material and methods. The bar diagram demonstrate the relative fold 
increase in the expression of mBD2 and mBD3 as compared to naïve 
cornea.  
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Figure 2. Reduced SK lesions and neovascularization in TLR2-/-, TLR2/4d-
/-, and MyD88-/- mice as compared to TLR9-/-, TLR4-/- and WT mice 
A. Bar diagram demonstrates the percentage severity of each group of mice 
(N=16) infected with 5 × 103 pfu HSV-1 RE at day 15 p.i. TLR2-/-, 
TLR2/4d-/-, MyD88-/- mice show reduced incidence (HSK score ≥ 3) of 
disease as compared to TLR9-/-, TLR4-/-, WT animals. 
B. Mean HSK lesion scores at day 8 and day 15 p.i of WT, TLR4-/-, TLR9-/-, 
TLR2/4d-/-, TLR2-/- and MyD88-/- mice infected with 5 × 103 pfu 
infection dose. ∗∗, (P ≤ 0.001) and ∗, (P ≤ 0.05), statistically significant 
differences as compared to WT control. 
C. Mean Angiogenesis lesion scores at day 8 and day 15 p.i of WT, TLR4-/-, 
TLR9-/-, TLR2/4d-/-, TLR2-/- and MyD88-/- mice infected with 5 × 103 
pfu infection dose. ∗∗ (P ≤ 0.001) and ∗ (P ≤ 0.05), statistically significant 
differences as compared to WT control animals. 
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Figure 3.  Compromised inflammatory cell influx into the cornea of TLR2-/- , 
TLR9-/-, TLR2/4d-/- , and MyD88-/- mice as compared to TLR4-/- and WT mice 
at 48 h p.i. 
Mice were infected with 5 x 103 pfu HSV-1 RE. Mice were terminated at 48 h p.i., 
and eyes were processed for cryo-sections. Hematoxylin and eosin staining was 
carried out on 6-µm sections. Dot plots associated with the sections represent the 
Gr1+CD11b+ cells in the WT and TLR4-/- corneas (Gr1+ on X-axis and CD11b+ 
on Y-axis). The numbers in the dot plots denote the percentage of inflammatory 
cells expressing both Gr1+ and CD11b+ markers. 
 67
                   
 
 
 
 
 
 
 68
Figure 4. Compromised cell infiltration into the TG of TLR2-/- and MyD88-/- 
mice as compared to TLR4-/- and WT mice 
 Single-cell suspensions of TG cells were prepared from four TGs at 48 h and 96 h 
p.i. for each group of mice. The cells were stained with FITC-labeled anti Gr-1, 
CD11c, F4/80 and PE labeled CD11b antibody. The number of positive cells was 
determined by FACS. The bars represent the number of cells/ 4×105 cells from the  
TG at 48 h and 96 h p.i. ∗, (P ≤ 0.05) and ∗∗, (P ≤ 0.01), statistically significant 
difference as compared to WT animals. 
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Figure 5. Reduced levels of cytokines and angiogenic factor in the corneas of 
TLR2-/- and MyD88-/- mice as compared to TLR4-/- and WT mice. 
At the indicated time points, six corneas/group were processed to measure the IL-
6, IL-1β, MIP-2 and VEGF levels. Levels of IL-6, IL-1β, MIP-2 and VEGF were 
estimated from the supernatants of corneal lysates of WT, TLR2-/-, TLR2/4d-/-, 
TLR4-/-, TLR9-/- and MyD88-/- animals infected with 5 × 103 pfu HSV-1 RE by 
an antibody capture ELISA as outlined in materials and methods. ∗, (P ≤ 0.05) and 
∗∗, (P ≤ 0.01), statistically significant difference as compared to WT animals. 
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Figure 6. Increased expression of proinflammarory cytokines and reduced levels 
of IL-10 in TLR4-/- animals as compared to WT 
At the indicated time points, six corneas/group and cervical DLNs from individual 
mice (N=4) were processed to measure the IL-10, IL-6, IFN-γ levels of WT and 
TLR4-/- animals infected with 5 × 103 pfu HSV-1 RE and cytokines measured by 
antibody capture ELISA as outlined in materials and methods. ∗, (P ≤ 0.05), 
statistically significant differences as compared to WT animals. 
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Figure 7. Reduced expression of COX-2 in TLR2-/- animals as compared to WT 
Single-cell suspensions of corneal cells were prepared from two corneas (Number 
of mice = 8) at day 3 and day 6 p.i. Intracellular COX-2 staining was carried out as 
described in materials and methods. In Fig. 7A and B, bar diagrams demonstrate 
the total number of COX-2+ cells and total number of COX-2+Gr1+ cells /1×105 
corneal cell respectively. ∗, (P ≤ 0.05), statistically significant differences as 
compared to WT animals. 
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 Table  1 
Percentage of mortality in various groups by day 15 p.i. 
 2 × 104 pfu/eye 5 × 103 pfu/eye 
WT 30 % < 20 % 
TLR4-/- 45 % < 20 % 
TLR9-/- <15 % - 
TLR2-/- <15 % - 
MyD88-/- 100 %  70 % 
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 Table  2 
aVirus titer in log10 pfu/ml in TG and brain at different time points p.i. 
Day4 p.i. Day7 p.i. 
 TG Brain TG Brain 
WT 3.2 ± 0.04 1.7 ± 0.29 bUD UD 
TLR9-/- 3.7 ± 0.08 2.3 ± 0.2 UD UD 
TLR2-/- 3.2 ± 0.03 2.3 ± 0.07 UD UD 
MyD88-/- 3.7 ± 0.06 2.2 ± 0.20 UD c3.8 ± 0.30 
a Mice were infected with 3 x 105 pfu of HSV-1 RE and killed at day4 or day7 
to measure viral titers using a standard plaque assay from brain and TG 
homogenates (n = 3).  
 b UD, Undetected, i.e., below the sensitivity of the assay (<10 pfu/ml) 
cVirus was also detected in the brain tissues collected from dying MyD88-/- 
mice (day-10-15). 
 
 77
Table  3 
aVirus titer in log10 pfu/ml in the cornea at different time points p.i 
 Day3 p.i. Day7 p.i. 
WT 3.2 ± 0.18 bUD 
TLR4-/- 3.7 ± 0.21 UD 
TLR9-/- 3.3 ± 0.17 UD 
TLR2-/- 3.1 ± 0.08 UD 
MyD88-/- 3.2 ± 0.10 UD 
a Mice were infected with 3 x 105 pfu of HSV-1 RE. Virus titer was estimated 
by standard plaque assay from swabs taken from infected corneas of mice (n = 
4) at the indicated time points.  
b UD, Undetected, i.e., below the sensitivity of the assay (<10 pfu/ml). 
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Part-III 
Enhanced viral immunoinflammatory lesions in 
mice lacking IL-23 responses.  
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Research described in this chapter is a slightly modified version of an article that 
in accepted for publication in Microbes and Infection by Pranita P Sarangi, 
Bumseok Kim, Ahmet Kursat Azkur,  Shilpa Deshpande Kaistha, and Barry T. 
Rouse 
*Kim B, *Sarangi PP, Ahmet Kursat Azkur, Deshpande Kaistha S, Rouse BT. 
Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. - 
Microbes and infections. 2008 (article in Press) * Equal contribution of authors. 
Copyright © 2008 Published by Elsevier Masson SAS 
In this chapter “our” and “we” refers to me and co-authors. My contribution in the 
paper includes (1) Selection of the topic (2) Compiling and interpretation of the 
literature (3) Designing experiments (4) understanding the literature and 
interpretation of the results (5) providing comprehensible structure to the paper (6) 
Preparation of graphs, figures and tables (7) Writing and editing 
Abstract 
Herpes simplex virus (HSV) infection of the cornea culminates in an 
immunopathological lesion (stromal keratitis – SK) that impairs vision. This report 
shows that HSV infection results in IL-23 up-regulation, but if this response fails 
to occur, as was noted in p19-/- mice, the severity of lesions, their incidence and 
the level of viral induced angiogenesis were significantly increased compared to 
wild-type (WT) animals (p < 0.05). The higher disease severity in p19-/- mice 
appeared to be the consequence of an increased IL-12 response that in turn led to 
the induction of higher numbers of IFN-γ producing CD4+ T cells, the principal 
orchestrators of SK. Our results indicate that the severity of HSV induced 
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immunopathological lesions may be mainly the consequence of IL-12 driven Th1 
T cell reactions rather than the action of IL-17 producing cells controlled by IL-23. 
Introduction 
Ocular infection with herpes simplex virus (HSV) culminates in 
immunoinflammatory lesions in the stroma (stromal keratitis – SK) that is a 
common cause of human blindness [1]. Understanding the pathogenesis of SK is 
expected to result in more effective control measures by targeting critical events. 
Studies in a mouse model of SK have revealed that many key events are set off by 
HSV infection. Among the early events are the production of several cytokines 
such as IL-6 and IL-12 [2, 3], chemokines such as MCP-1 and MIP-2 [4, 5] as well 
as several molecules that induce neovascularization of the normally avascular 
cornea [6]. Past studies by us and others have shown that IL-12 is upregulated by 
HSV infection [2, 7] and may be involved in generating IFN-γ producing CD4+ T 
cells that are thought to be the main orchestrators of SK lesions [8]. In support of 
this, animals unable to generate normal IL-12 responses develop diminished 
lesions [2]. Currently, the role of the structurally similar IL-23 molecule in the 
pathogenesis of SK is not understood. This topic is of interest since several 
autoinflammatory and some anti-microbial inflammatory reactions that were 
formerly thought to be mainly IL-12/IFN-γ mediated immunoinflammatory events 
were subsequently shown to be more the consequence of responses influenced by 
IL-23 that promotes the expansion and survival of pathogenic IL-17 producing T 
cells [9-11]. Although T cells that produce IL-17 have been demonstrated in 
human SK lesions [12] the respective role of Th1 and Th17 pathogenic T cells as 
orchestrators of SK is poorly understood. The present report evaluates the role of 
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the IL-23/IL-17 axis in SK by comparing the outcome of infection in wild-type 
(WT) to those in mice unable to generate IL-23 because of p19 knockout. Our 
results show that HSV infection causes the upregulation of IL-23 but these results 
in only minimally detectible CD4/IL-17 producing responses in the eye. 
Furthermore lesions were significantly more severe in animals unable to produce 
IL-23 making it doubtful if the IL-23/IL-17 axis is mainly responsible for the 
ocular inflammatory lesions. In fact, in the absence of p19 more abundant IL-12 
and Th1 responses were evident. We presume it is the IFN-γ producing Th1, rather 
than Th17 T cells, that are mainly responsible for mediating SK.  
Materials and Methods 
Mice 
Female C57BL/6 mice, 6 to 7 weeks old, were purchased from Harlan Sprague-
Dawley (Indianapolis, IN). P19 deficient mice were kindly provided by Dr. Nico 
Ghilardi (Genentech, Inc., CA). All investigations followed guidelines of the 
Committee on the Care of Laboratory Animals Resources, Commission of Life 
Sciences, National Research Council. The animal facilities of the University of 
Tennessee (Knoxville) are fully accredited by the American Association of 
Laboratory Animal Care. 
Virus 
HSV-l strain RE (kindly provided by Dr. Robert Lausch, University of Alabama, 
Mobile, AL) was used in all procedures. Virus was grown in Vero cell monolayers 
(American Type Culture Collection, Manassas, VA; Cat. no. CCL81), titrated, and 
stored in aliquots at -80°C until used.  
 
 82
Corneal HSV infection 
Corneal infections of all mouse groups were conducted under Avertin deep 
anesthesia. The mice were scarified lightly on their corneas with a 30-gauge 
needle, and a 2 µl drop containing different plaque-forming units (PFU) of HSV-1 
RE was applied to the eye and gently massaged with the eyelids.  
Real-time quantitative PCR  
The total cellular RNA was isolated from corneas and draining lymph nodes 
(DLNs) by using an RNeasy protect mini kit (Qiagen, Valencia, CA) according to 
the manufacturer’s instruction. All samples were treated with RNase-free DNase 
(Qiagen). The extracted RNA was reverse transcribed using oligo (dt) primers and 
reverse transcriptase enzyme (Promega, Madison, WI) according to standard 
protocol. The cDNA obtained was used as a template for real-time quantitative 
PCR and real-time PCR was performed using a QuantiTect SYBR Green PCR kit 
(Qiagen). The primers used were murine p19 forward 
(TGCTGGATTGCAGAGCAGTAA) and reverse 
(GCATGCAGAGATTCCGAGAGA). Initially, mRNA levels were normalized to 
the GAPDH mRNA level. Briefly, a standard curve was generated using the PCR 
product of interested gene cloned into a pCR-XL-TOPO vector (Invitrogen, San 
Diego, CA). After spectrophotometric determination of the plasmid DNA 
concentration, the copy number was calculated using the following formula: (X 
g/µl DNA/ (plasmid length in bp × 660) × 6.022 × 1023 = Y molecules/µl). Test 
samples were run in triplicate with a dilution series and the mean value of a 
particular dilution was used. Data are expressed as copy number per sample. 
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 Clinical observations  
The eyes were examined on different days after infection for the development of 
clinical lesions by slit-lamp biomicroscopy (Kawa Co, Nagoya, Japan), and the 
clinical severity of keratitis of individually scored mice was recorded. The scoring 
system was as follows: 0, normal cornea; +1, mild corneal haze; +2, moderate 
corneal opacity or scarring; +3, severe corneal opacity but iris visible; +4, opaque 
cornea and corneal ulcer; +5, corneal rupture and necrotizing stromal keratitis. The 
severity of angiogenesis was recorded as described previously [6]. In reference to 
the angiogenic scoring system, the method relied on quantifying the degree of 
neovessel formation based on three primary parameters: 1) the circumferential 
extent of neovessels (as the angiogenic response is not uniformly circumferential in 
all cases); 2) the centripetal growth of the longest vessels in each quadrant of the 
circle; and 3) the longest neovessel in each quadrant was identified and graded 
between 0 (no neovessel) and 4 (neovessel in the corneal center) in increments of 
~0.4 mm (radius of the cornea is ~1.5 mm). According to this system, a grade of 4 
for a given quadrant of the circle represents a centripetal growth of 1.5 mm toward 
the corneal center. The score of the four quadrants of the eye were then summed to 
derive the neovessel index (range, 0 to 16) for each eye at a given time point.  
Cytokine assay 
For cytokine (IFN-γ, IL-12p35, IL-12p40) assay, splenocytes from mice were 
suspended in 10% RPMI-1640, and 106 cells in 1 ml were stimulated in vitro with 
irradiated syngeneic-enriched naïve splenocytes pulsed with UV-inactivated HSV 
(MOI, 1.5 before UV inactivation).  Similar number of cells was Con A-stimulated 
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(5 μg/106 cells/ml) in 96-well plates. Plates were incubated at 37°C for 72 h. The 
supernatant fluid was collected and stored at -80°C until use. These supernatants 
were screened for the presence of individual cytokines by enzyme-linked 
immunosorbent assay (ELISA). 
Flow cytometric analysis 
Single-cell suspensions were prepared from the SK corneas or lymphoid organs 
(spleen and DLNs). For the preparation of corneal samples, four corneas per group 
were dissected, pooled together, and digested with 60 U/ml Liberase (Roche 
Diagnostics, Alamenda, CA) for 60 min at 37°C in a humidified atmosphere of 5% 
CO2. After incubation, the corneas were disrupted by grinding with a syringe 
plunger on a mesh and a single-cell suspension was made in complete RPMI 1640 
medium. Next, the single-cell suspensions obtained from corneal or lymphoid 
samples were stained for FACS. Briefly, single cells were first blocked with an 
unconjugated anti-CD32/CD16 mAb (BD Biosciences, San Jose, CA) for 15 min 
at 4°C in FACS buffer and stained by anti-CD4-APC, anti-CD8-PerCp, CD11c-
PerCp, or CD11b-APC antibody (BD Biosciences) for 30 min. Cells were fixed 
and permeabilizied using Cytofix/Cytoperm (BD Biosciences) solution for 
approximately 30 minutes, followed by washing with perm washing solution. 
Intracellular staining was done with anti-IFN-γ-PE, anti-IL-12-PE, or anti-IL-17-
PE antibody (BD Biosciences) for 30 minutes on ice and washed twice with perm 
wash. Finally, the cells were washed with FACS buffer and samples were acquired 
on a FACScan (BD Biosciences). The data were analyzed using the CellQuest 3.1 
software (BD Biosciences).  
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Protein quantification of corneal or lymphoid organs lysates by ELISA 
The lysates from HSV infected cornea or lymphoid organs (spleen and DLNs) 
were used for the measurement of IFN-γ, IL-12, IL-23, or TGF-β by a standard 
sandwich ELISA protocol. For preparation of sample lysates, four corneas or 
lymphoid organs/time point (n = 4) were collected and minced with liquid 
nitrogen. Minced pieces were collected in 1 ml of DMEM without FCS and 
homogenized using an ultra sonicater (Heat systems-Ultrasonics, NY). The lysates 
were then clarified by centrifugation at 12,000 rpm for 5 min at 4°C. The 
supernatant was collected and stored at –80°C till further use. The ELISA plate 
was coated with anti-mouse capture antibody (100 μl/well of the capture antibody 
at various concentrations, BD Biosciences) and incubated at 4°C overnight. The 
plate was washed with 0.05% tween20/PBS and blocked with 3% BSA for 2 h at 
37°C. After washing, serially diluted lysates were added to the plate and incubated 
at 4°C overnight. The plate was washed and then incubated with biotinylated 
detection antibody (BD Biosciences) for 2 h. Finally, peroxidase-conjugated 
streptavidin (Jackson ImmunoResearch Laboratory, PA) was added. The color 
reaction was developed using ABTS (Sigma-Aldrich, St. Louis, MO) and 
measured with an ELISA reader (Spectramax 340; Molecular Devices, Sunnyvale, 
CA) at 405 nm. Quantification was performed with Spectramax ELISA reader 
software version 1.2. 
Virus recovery and titration
Swabs of the corneal surface were collected at various time points post infection 
(p.i.). The swabs were put into sterile tubes containing 600 μl serum free DMEM 
with 10 international units (IU) penicillin/ml and 100 µg streptomycin (Life 
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Technologies, Grand Island, NY)/ml and were stored at -80°C. For detection and 
quantification of virus, the samples were thawed and vortexed. Individual 
subsamples (200 μl each sample) were diluted further, and viral titers were 
determined by a plaque assay performed on Vero cells as described elsewhere [13]. 
Statistical analysis 
Significant differences between groups were evaluated by using the Student’s t 
test. P < 0.05 was regarded as a significant difference between two groups. Results 
are expressed as mean ± standard error. 
Results  
Expression of IL-23 after HSV-1 infection 
WT C57BL/6 mice were infected with HSV-1 (5 × 105 PFU) and at various times 
p.i. were killed to determine the levels of p19 mRNA by quantitative real-time 
PCR in both corneal and DLNs RNA samples. As is shown in Fig.1A, minimal or 
undetectable mRNA levels of p19 were present in naïve corneas or lymph nodes, 
but by day 2 p.i. abundant levels of IL-23 mRNA were detected. In other 
experiments, IL-23 protein levels were quantified in corneal extracts as well as 
extracts of lymphoid organs by ELISA in animals infected with different doses of 
virus (5 × 103, 5 × 104, 5 × 105 PFU). Peak levels were found with the highest dose 
used for infection (Fig. 1B). These results indicate that IL-23 is up-regulated by 
HSV infection and could perhaps participate in the immunopathogenesis of 
herpetic SK. 
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The absence of IL-23 production results in more severe disease 
The expression of disease was compared in WT and p19-/- mice at various times 
p.i. upon infection with different doses of virus (5 × 103, 5 × 104, 5 × 105 PFU). At 
high doses of virus used for infection (5 × 104 and 5 × 105 PFU) disease severity in 
both WT and p19-/- animals was of similar magnitude (Fig. 2A). However, at a 
low dose of infection (5 × 103 PFU) highly significant differences were observed 
in the susceptibility of WT and p19-/- animals. In the latter, more eyes developed 
lesions and the mean severity scores of both angiogenesis and SK lesions were 
significantly more severe than in WT animals (P < 0.05, Fig. 2B). Lesions also 
occurred slightly earlier in p19-/- animals. Overall an average result of three 
separate experiments reveal that 80% of p19-/- developed SK of 3 or greater where 
as only 33% of WT animals developed such severity (Fig. 2C). Thus the failure to 
generate an IL-23 response results in more severe lesions at least at minimal doses 
of infection. 
 As the presence of replicating virus may contribute to lesion severity, we 
compared the levels of virus in the eye swabs collected from both groups of 
animals at different time points.  As is evident in Fig. 2D, virus clearance occurred 
earlier in the corneas of p19-/- as compared to WT animals (p < 0.05). Thus 
although lesions were more severe in p19-/- animals virus was cleared from the 
epithelium earlier than in WT. 
P19-/- animals develop more severe Th1 immune response 
In an attempt to explain why p19-/- mice showed more severe responses than WT 
animals, we infected both groups with the low dose of virus (5 × 103 PFU) and 
lymphoid samples were collected at day 20 post infection to compare the 
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magnitude of the HSV specific T cell responses. This was done by stimulating T 
cells with antigen and comparing the induced cytokine response by ELISA. As 
shown in Fig. 3A, splenocytes from p19-/- mice produced significantly higher (p < 
0.05) levels of IFN-γ as compared to WT controls. Similarly, although no 
difference was observed in the production of p40 subunit, the IL-12p35 level was 
significantly higher in p19-/- as compared to WT (p < 0.05). These results may 
mean that in the absence of p19 the Th1 type of immune response is increased. 
To determine which cell populations contribute to the Th1 type immune 
response against HSV, isolated splenocytes from both groups having SK lesions 
were stimulated with anti-CD3 and anti-CD28 to analyze cytokine production. As 
assessed by intracellular cytokine staining assay, the percentage and absolute 
number of IFN-γ expressing CD4+ T cells as well as IFN-γ expressing CD8+ T 
cells was significantly higher (p < 0.05) in p19-/- mice as compared to WT control 
animals (Fig. 3B). Similar results were also obtained when cells were stimulated 
with syngeneic naive splenocytes pulsed with HSV (Fig. 3C). In addition, we also 
compared the numbers of IL-12 producing cells in the infected DLNs and spleen 
in the two groups of animals. As shown in Fig. 4A, higher numbers of IL-12 
expressing cells were noted in the p19-/- animals as compared to WT. The 
majority of cells producing IL-12 were found to be CD11c+ CD11b- (Fig. 4B). 
Total cell numbers in the DLNs and spleen of p19-/- were marginally increased as 
compared to WT animals (not shown) indicating that relative population of IFN-γ 
or IL-12 expressing cell types were greater in lymphoid organs of p19-/- animals. 
Thus these data indicate that p19-/- mice generated a greater Th1 type of immune 
response than did WT animals. 
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 The nature of the response in p19-/- and WT corneas was also measured 
using corneas isolated from the infected animals of both the groups. As shown in 
the Fig. 5A, the protein levels of IFN-γ and IL-12 were significantly higher in the 
lysates of p19-/- corneas as compared to WT at day 20 p.i. (p < 0.01). We next 
determined the number of IFN-γ expressing cells in the collagenase digested 
corneas of each group. As shown in Fig 5B, there was approximately two and four 
fold increase in the total number of IFN-γ producing cells in the p19-/- corneas 
after anti-CD3 and CD28 stimulation at day 10 and day 20 respectively as 
compared to WT. Such IFN-γ producing cell types in SK corneas were mainly 
CD4+ T cells confirming that pathogenesis of herpetic SK is contributed by Th1 
type CD4+ T cells (Fig. 5C). Similarly, the numbers of IL-12 producing cells were 
also higher in p19-/- corneas as compared to WT controls (Fig. 5B). Total cell 
numbers in the SK cornea of p19-/- mice were also greater than those of WT mice 
at day 10 and 20 p.i. (Fig. 5D) suggesting both absolute numbers and frequencies 
of such cells in the corneas of p19-/- animals were higher as compared to WT 
animals. These data indicate that the p19-/- mice generated a more abundant Th1 
type of immune response in the corneas than WT. 
P19-/- mice develop less Th17 immune response 
Previous studies showed that IL-23 expands a pathogenic CD4+ T cell population 
that produces IL-17 and contributes to inflammation [9]. To record such an effect, 
isolated splenocytes, DLN cells, and corneal cells from both groups having SK 
lesions were stimulated with anti-CD3 and anti-CD28 to analyze IL-17 production.  
As assessed by intracellular cytokine staining assay, comparable and little levels of 
IL-17-producing CD4+ T cells were observed in the spleen, DLNs, and corneas of 
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both p19-/- and WT mice at day 10 post infection (data not shown). At day 20 post 
infection, however, higher levels of IL-17-producing CD4+ T cells were observed 
in the SK cornea, spleen, and DLNs of WT compared to p19-/- mice (Fig. 6A). 
Since TGF-β is critical for the induction of Th17 cells [14], we measured the 
protein levels of TGF-β  in the corneas and lymphoid tissues of p19-/- and WT 
animals.  We could not find significant differences in the TGF-β levels in the 
naïve and infected p19-/- animals corneas as compared to WT. Interestingly, 
significantly higher levels of TGF-β was found in the cervical DLNs but not the 
spleens of p19-/- animals at 5 days p.i. (Fig. 6B). These data indicate that IL-23 is 
needed for the maintenance of the Th17 cells post infection. 
Discussion 
 In many immunoinflammatory lesion events thought formerly to represent 
the consequences of IL-12 controlled IFN-γ producing Th1 type T effector cells 
were subsequently shown to be more the consequence of pathologic CD4+ T cells 
that produce IL-17 [11]. The differentiation and expansion of the latter was 
influenced by IL-23 rather than IL-12. We, and others, had shown the relevance 
and importance of IL-12 and IFN-γ producing CD4+ T cells in the orchestration of 
HSV induced inflammatory reactions in the cornea [1, 2, 8, 15, 16], but any role 
for Th17 mediated events had not been studied. The present investigation shows 
that ocular infection does result in IL-23 induction but the extent of the ocular 
Th17 response in the cornea was very limited. Furthermore, we observed that the 
severity of HSV induced SK lesions were in fact more severe than in WT animals 
if mice were unable to generate IL-23 because of p19 knockout. Thus in this viral-
induced immunopathological reaction, SK lesions would appear to be mainly 
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orchestrated by Th1 cells as advocated by several groups prior to our knowledge 
about the existence of the IL-23/IL-17 axis of inflammatory disease mediation. 
 The evidence that the IL-12/IFN-γ and IL-23/IL-17 represent separate 
mechanisms of cell mediated tissue damage appears now to be well accepted [9, 
11, 17, 18]. In fact, based on the use of knockout animals, as well as approaches 
using in vivo cytokine neutralizing antibodies, the trend has usually been to show 
that lesions assumed to represent the consequence of IL-12/ IFN-γ mediated events 
in fact primarily involved IL-23/IL-17 mediated mechanisms. This has been 
shown true for several autoimmunities and some inflammatory reactions against 
microbes [10, 11, 17]. Reasons why one type of inflammatory reaction prevails 
over another are usually not available. However, with some microbes and some 
purified microbial products more effective induction of IL-23 compared to IL-12 
has been show to occur. This happens with Bordetella pertussis [19] as well as 
with stimulation by peptidoglycan from Staphylococcus aureus [20]. In addition, 
various toll-like receptor (TLR) ligands were shown to differentially stimulate IL-
12 and IL-23 production from dendritic cells (DCs) [21, 22]. HSV has been shown 
to possess both TLR2 and 9 ligand activity [23] and in addition causes the release 
of endogenous TLR ligands such as hsp70 from infected cells [24, 25]. One or 
more of these TLR ligands could stimulate IL-12 and IL-23 production 
differentially in SK corneas. We are currently attempting to compare the relative 
IL-12/IL-23 inducing capacity of HSV, infected cell extracts and known TLR 
ligands in various cell types derived from the eye. We anticipate that HSV may be 
a better inducer of IL-12 than IL-23 and that the resultant IFN-γ response from 
innate cells, that includes neutrophils [26], may serve to suppress any concomitant 
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Th17 responses. Such suppression of Th17 responses by IFN-γ has been shown to 
occur in vitro [27]. Moreover, HSV may also be a weak inducer of TGF-β which 
appears to act as a cofactor for Th17 development [28]. In our current study, there 
was no significant increase in the TGF-β levels in the WT corneas post infection. 
Additionally, we did not find any significant difference in the levels of TGF-β in 
the corneas of p19-/- animals as compared to WT animals.  Taken together these 
events may explain the minimal Th17 response in the eye during HSV induced 
immunopathology, and such ideas are being further investigated. 
 Arguing forcefully against a major role for IL-23/Th17 induced tissue 
damage in the SK system was the observation that without the ability to produce 
IL-23 because of p19-/-, lesions were more severe than in WT. In preliminary 
results, we have also confirmed the previous observation of the Ghiasi group [2] 
that corneal scarring becomes less severe in animals unable to make IL-12 because 
of p35-/-. Moreover, animals unable to respond to IL-12 because of STAT4 
knockout develop only mild lesions of SK [29]. The reasons for the enhanced 
pathology in p19-/- animals appeared to be associated with the increased IL-12/ 
IFN-γ response that occurred in such animals. These enhanced responses were 
noted both in the spleen as well as in ocular inflammatory sites. The better IFN-γ-
producing CD4+ T cell response likely accounted for the more severe SK lesions in 
p19-/- animals. Presumably in the absence of p19 more of the available p40 
subunit may be able to dimerize with p35 subunit leading to more IL-12 
production. Such a finding was also suggested to the observation of Becker et al 
[22] in an experimental colitis model wherein p19-/- animals were shown to 
develop more severe colitis than the intact animals. They also observed elevated 
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levels of IL-12 production and the reversal of the phenotype by administration of 
blocking antibody to the p40 subunit.  
In our model, p19-/- animals also cleared the infecting virus more promptly 
presumably because of the enhanced production of IFN-γ in p19-/- compared to 
WT animals. Furthermore, greater numbers of CD11c+CD11b+ cells as well as 
CD11c+CD11b- cells were also observed in the ocular tissues of p19-/- animals 
compared to WT (data not shown). Such cells may be myeloid and plasmacytoid 
DCs respectively, an abundant source of IFN-α which also might explain the more 
rapid clearance of virus from the eyes of p19-/- animals [30]. 
In summary, our results make the case that SK remains a disease whose 
mechanism of tissue damage appears to be mainly the consequence of an IL-12 
influenced Th1 IFN-γ producing type of T cell rather than by a pathogenic Th17 
producing mechanism. The latter likely plays only a minor role but this might 
synergize with the Th1 pathogenic response as has been suggested to occur in 
EAE model [31]. We are currently attempting to confirm our observations using 
adoptive T cell transfer approaches with in vitro generated Th1 and Th17 specific 
cells along with evaluating the effects of inhibition studies with specific anti-sera. 
Understanding the mechanisms is considered important as it could impact on 
measures used to control this important tissue damaging disease process.   
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Figure 1. Expression of IL-23p19 mRNA and protein in the corneas and 
lymphoid organs after HSV-1 ocular infection 
(A) WT mice were infected with 5 × 105 PFU of HSV-1 on their scarified corneas. 
At different time points, mRNA was extracted from the corneas and DLNs, and 
reverse transcribed into cDNA. Kinetic expression of IL-23p19 mRNA was 
measured by real-time PCR. Test samples were run in triplicate with a dilution 
series and the mean value of a particular dilution was used. Data are expressed as 
copy number per sample. (B) WT mice (n = 3) were ocularly infected with 
different doses of virus (5 × 105, 5 × 104, 5 × 105 PFU) and levels of IL-23 protein 
were estimated from lysate supernatants of corneas, DLNs, or spleen of mice by an 
antibody capture ELISA as described by materials and methods. 
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Figure 2. IL-23p19-/- mice have higher SK lesion severity, incidence, ocular 
angiogenesis, and enhanced viral clearance 
Corneas of IL-23p19-/- and WT mice (n = 4) were infected with various doses of 
HSV-1 (5 × 103, 5 × 104, 5 × 105 PFU), and the levels of SK severity and 
neovascularization were measured in the corneas by biomicroscopy in groups of 
p19-/- (•) and WT (ο) mice. (A) SK lesion severity and angiogenesis scoring was 
conducted on day 18 p.i.. Results are representative of one of three independent 
experiments. Statistically significant differences in SK and angiogenic score were 
observed between the groups (** p < 0.01). (B)  Stromal lesion severity and 
angiogenesis in IL-23p19-/- and WT mice (n = 4) infected with low dose of HSV-
1 (5 × 103 PFU) were measured at different time intervals. Results are 
representative of three independent experiments. Statistically significant 
differences in SK and angiogenic score were observed between the groups (* p < 
0.05, ** p < 0.01). Images were taken by stereomicroscopic imaging system at day 
19 after virus infection (original magnification, × 40). (C) The incidence of clinical 
SK lesions was considered as over score 2 at day 14 p.i.. (D) Infectious virus titers 
were compared in the different mice groups (n = 4) following virus infection with 
5 × 103 PFU.  At days 4 and 6 p.i., swabs of the corneal surface were collected and 
were put into serum free DMEM with antibiotics. Individual samples were diluted 
further, and viral titers were determined by a plaque assay performed on Vero cells 
as described materials and methods. Statistically significant differences in number 
of virus on the cornea (* p < 0.05) were observed between the groups. 
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Figure 3. Increased Th1 type immune responses in the spleen of IL-23p19-/- 
mice after HSV-1 infection 
(A) At day 20 p.i. (5 × 103 PFU/eye), spleen cells of the different mice groups 
were used in antigen specific ELISA. For cytokine ELISA assay, splenocytes from 
mice were sampled, suspended, and stimulated with irradiated syngeneic-enriched 
naïve splenocytes pulsed with UV-inactivated HSV (MOI, 1.5) at 37°C for 72 h. 
Levels of individual cytokines were estimated from supernatant fluid by an 
antibody capture ELISA as outlined in materials and methods. Statistically 
significant differences in levels of individual cytokines (* p < 0.05, ** p < 0.01) 
were observed between the groups. At day 10 and 20 p.i., splenocytes of the 
different mice groups (n = 4) were used in intracellular cytokine staining assay. 
For intracellular cytokine staining assay, isolated spleen cells from both groups 
having SK lesions were stimulated with anti-CD3 and anti-CD28 (B) or stimulated 
with syngeneic naïve splenocytes pulsed with HSV (C) for 16 h. Single cells were 
extracellularly stained with anti-mouse CD4 (APC) and CD8 (PerCp) antibody and 
then intracellularly stained with anti-mouse IFN-γ PE antibody. Values shown in 
each graph reflect the percentage or number of spleen cells expressing IFN-γ. 
Statistically significant differences were observed between the groups (* p < 0.05, 
** p < 0.01). Results are representative of two independent experiments. 
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Figure 4. Increased population and number of IL-12 expressing cells in the 
lymphoid organs of p19-/- mice after HSV-1 infection 
At day 10 and 20 p.i., splenocytes or DLNs cells of the different mice groups (n = 
4) were used in intracellular cytokine staining assay. Isolated splenocytes or DLNs 
cells from both groups having SK lesions were stimulated with anti-CD3 and anti-
CD28  for 16 h. Single cells were extracellularly stained with anti-mouse CD11b 
(APC) and CD11c (PerCp) antibody and then intracellularly stained with anti-
mouse IL-12 PE antibody (A and B). Values shown in each graph reflect the 
percentage or absolute number of spleen cells expressing IL-12. At day 10 and 20 
p.i., total numbers of splenocytes and DLNs cells of the different mice groups (n = 
6) were measured (C).  
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Figure 5. Increased Th1 type immune responses in the SK corneas of p19-/- 
mice 
At day 20 p.i., 6 corneas/group that were infected with 5 × 103 PFU HSV-1 were 
processed to measure the IFN-γ or IL-12 cytokine levels (A). Levels of individual 
cytokines were estimated from supernatants of corneal lysates of mice by an 
antibody capture ELISA as outlined in materials and methods. Statistically 
significant differences in levels of cytokines (** p < 0.01) were observed between 
the groups. Alternatively, isolated corneal cells from both groups having SK 
lesions (10 and 20 post infection) were stimulated with anti-CD3 and anti-CD28 
for 16 h. Single cells were extracellularly stained with anti-mouse CD4 APC 
antibody and then intracellularly stained with anti-mouse IFN-γ or IL-12 PE 
antibody (B and C). Cells were gated on lymphocytes and values shown in each 
plot represent the percentage of CD4+ T cells expressing IFN-γ (C). At day 10 and 
20 p.i., total cell numbers of collagenase digested cornea of the different mice 
groups (n = 6) were measured (D). Statistically significant differences in the 
absolute cell numbers of SK cornea (* p < 0.05, ** p < 0.01) were observed 
between the groups. 
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 Figure 6. Decreased Th17 immune response in p19-/- mice after HSV-1 
infection 
At day 20 p.i., splenocytes, DLN cells, and corneal cells from WT and p19-/- mice 
having SK lesions were stimulated with anti-CD3 and anti-CD28 for 16 h. Single 
cells were extracellularly stained with anti-mouse CD4 APC antibody and then 
intracellularly stained with anti-mouse IL-17 PE antibody. Cells were gated on 
lymphocytes and values shown in each plot represent the percentage of cells 
expressing IL-17 (A). Data are representative of two similar experiments. At day 5 
and 9 p.i., DLNs, spleen, and 6 corneas/group that were infected with 5 × 103 PFU 
HSV-1 were processed to measure the TGF-β cytokine levels (B). Levels of TGF-
β were estimated from supernatants of each tissue’s lysates of mice by an antibody 
capture ELISA as outlined in materials and methods. 
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Part-IV 
IL-10 and natural regulatory T cells: Two 
independent anti inflammatory mechanisms in 
HSV induced ocular immunopathology 
 114
Research described in this chapter is a slightly modified version of an article that 
in accepted for publication in Journal of Imunology by Pranita P Sarangi, Sharvan 
Sehrawat, Susmit Suvas, and Barry T. Rouse 
Sarangi PP, Sehrawat S, Suvas S and Rouse BT. IL-10 and natural regulatory T 
cells: Two independent anti inflammatory mechanisms in HSV induced ocular 
immunopathology. (Journal of Immunology-Accepted) 
In this chapter “our” and “we” refers to me and co-authors. My contribution in the 
paper includes (1) Selection of the topic (2) Compiling and interpretation of the 
literature (3) Designing experiments (4) understanding the literature and 
interpretation of the results (5) providing comprehensible structure to the paper (6) 
Preparation of graphs, figures and tables (7) Writing and editing 
Abstract 
 
Two prominent anti-inflammatory mechanisms involved in controlling HSV-1 
induced corneal immunopathology (Stromal Keratitis-SK) are the production of 
the cytokine IL-10 and the activity of natural regulatory T cells (nTregs). It is not 
known whether under in vivo conditions, IL-10 and nTregs influence the corneal 
pathology independently or in concert. In the current study using wild-type (WT) 
and IL-10-/- animals, we have assessed the activity of nTregs in the absence of IL-
10 both under in vitro and in vivo conditions.  The IL-10-/- animals depleted of 
nTregs prior to ocular infection showed more severe SK lesions as compared to 
the undepleted IL-10-/- animals. In addition, nTregs purified from naïve WT and 
IL-10-/- animals were equally able to suppress the proliferation and the cytokine 
production from anti-CD3 stimulated CD4+CD25- T cells in vitro. Furthermore, 
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intracellular cytokine staining results indicated that non regulatory cells expressing 
B220 and CD25 markers were the major IL-10 producing cell types in the 
lymphoid tissues of HSV infected mice. In contrast, in the infected corneas, cells 
with the CD11b+Gr1+ phenotype along with a minor population of Foxp3-CD4+ 
and a few F4/80+ cells produced IL-10.  Our current investigations indicate that at 
least two independent anti-inflammatory mechanisms are involved in limiting the 
corneal lesions in SK, both of which may need to be modulated to control SK 
therapeutically. 
Introduction 
 
Ocular infection with herpes simplex virus (HSV) results in a chronic 
immunoinflammatory reaction in the cornea that can result in blindness. Studies in 
animal models of stromal keratitis (SK) have revealed that the infection, possibly 
in part because of its TLR ligand activity sets off a range of critical cellular and 
molecular events [1], but the actual SK lesions appear to be orchestrated mainly by 
CD4+ T cells that are primarily type 1 cytokine producers [2, 3]. SK lesions may 
resolve spontaneously and when this occurs in the mouse model, it may be 
associated with the up regulation of IL-10 production [4]. Additionally, the 
severity of SK may also be affected by the activity of Foxp3+ regulatory T cells 
[5]. Accordingly, the depletion of such cells may result in more severe lesions [5] 
and recently we have shown that the adoptive transfer of in vitro generated Foxp3+ 
Tregs may modulate the severity of SK lesions [6]. 
One potential mechanism by which the Tregs carry out their regulatory 
effects is by the production of inhibitory cytokines such as IL-10 and TGF-β  [7]. 
In fact some types of Tregs may be induced by IL-10 and mediate regulation 
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principally by producing IL-10 [8]. In some infectious disease models, these 
inducible Tregs (sometimes referred to as Tr1 cells) are considered to play a 
pivotal role in viral pathogenesis [9]. That IL-10 is critical for resolution of 
inflammatory lesions has been shown in many systems including SK [10]. Thus 
SK lesions may be more severe in IL-10-/- animals [11] but it is unclear if this 
reflects the failed function of some type of regulatory T cell or be the consequence 
of failure of IL-10 production by some innate inflammatory cell type. Thus 
macrophages and some dendritic cells (DCs) subtypes as well as highly activated 
CD4+ T cells may be major sources of IL-10 production [12, 13] and certain 
pathogens may encode ligands that can stimulate IL-10 production from some 
cells [14, 15]. 
 In the present study, we have compared the pathogenesis of SK in wild-
type (WT) and IL-10-/- mice in an attempt to further define if Treg mediated 
control of the inflammatory reaction is dependent or independent of IL-10 
production. Our results show that compared to WT controls increased SK lesions 
occur in the absence IL-10 as well as if nTregs are deleted. Interestingly, depletion 
of nTregs even in IL-10-/- animals resulted in even more enhanced SK lesion 
severity compared to IL-10-/- mice indicating that the effect of Tregs mainly 
occurred independently of IL-10 production. In support of this finding, Tregs 
purified from IL-10-/- and WT appeared equally active at suppression and could 
inhibit the cytokine production from TCR stimulated CD4+CD25- T cells isolated 
from naive and infected WT animals. Furthermore, in the infected corneas, non 
regulatory cells with the CD11b+Gr1+ phenotype along with a minor population of 
Foxp3-CD4+ and a few F4/80+ cells produced IL-10. Our results show that at least 
 117
two independent anti-inflammatory mechanisms namely, IL-10 and nTregs are 
involved in controlling corneal immunopathology in SK. We discuss the 
implication of our studies for future novel therapies for SK 
Material and methods 
 
Animals 
IL-10-/- breeders were obtained from the Jackson laboratory (Bar Harbor, ME) and 
were maintained in the animal facility of University of Tennessee. C57BL/6 mice 
were obtained from Harlan Sprague-Dawley, (Indianapolis IN). Foxp3-GFP mice 
[16] were kind gift from Dr.Mohammed Oukka (Harvard Medical School). To 
prevent bacterial superinfection, all mice received prophylactic treatment with 
Sulfamethoxazole/Trimethoprim (Biocraft, Elmond Park, NY) at the rate of 5 
ml/200 ml drinking water after virus infection. All experimental procedures 
followed the guidelines the Association for Research in Vision and 
Ophthalmology resolution on the use of animals in research. The animal facilities 
of the University of Tennessee (Knoxville) are fully accredited by the American 
Association of Laboratory Animal Care. 
In vivo depletion of nTregs and HSV-1 infection 
IL-10-/- and C57Bl/6 animals were given 0.7mg of anti-CD25 monoclonal 
antibody pc61 mAb (Bioexpress) i/p, 3 days prior to corneal infection. Depletion 
was tested by staining for CD4+CD25+ cells in the spleen and lymph nodes (Fig. 
1A). More than 80% depletion was achieved by day 3 after depletion. HSV-1 
strain RE (obtained from R. Lausch, University of South Alabama College of 
Medicine) was used in all procedures. Virus was propagated and stored as 
described previously [17]. For all experiments 6-8 week old females were used 
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except for comparison of IL-10-/- with Treg depleted IL-10 animals in which 9-10 
week old male mice were used. Corneal infections of all mouse groups were 
conducted under deep anesthesia induced by intra-peritoneal injection of Avertin 
(Sigma-Aldrich.St.Louis, MO). The mice were scarified on their corneas with a 27 
gauge needle and infected with a 3 μl drop containing 5 × 105 plaque-forming units 
(PFU) of HSV-1 was applied to the eye and gently massaged with the eyelids. 
Clinical observation 
The eyes were examined on different days post infection (p.i.) for the development 
of clinical lesions by slit-lamp biomicroscopy (Kawa Co., Nagoya, Japan), and the 
clinical severity of keratitis lesions and development of neovascularization of 
individually scored mice was recorded as described previously [18]. In brief, the 
scoring system was as follows: 0, normal cornea; +1, mild corneal haze; +2, 
moderate corneal opacity or scarring; +3, severe corneal opacity but iris visible; 
+4, opaque cornea and corneal ulcer; +5, corneal rupture and necrotizing stromal 
keratitis. Similarly, the angiogenic scoring system relied on quantifying the degree 
of neovessel formation based on three primary parameters: 1) the circumferential 
extent of neovessels (as the angiogenic response is not uniformly circumferential in 
all cases); 2) the centripetal growth of the longest vessels in each quadrant of the 
circle; and 3) the longest neovessel in each quadrant was identified and graded 
between 0 (no neovessel) and 4 (neovessel in the corneal center) in increments of 
~0.4 mm (radius of the cornea is ~1.5 mm). According to this system, a grade of 4 
for a given quadrant of the circle represents a centripetal growth of 1.5 mm toward 
the corneal center. The score of the four quadrants of the eye were then summed to 
derive the neovessel index (range, 0 to 16) for each eye at a given time point. 
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Histopathology 
For histopathologic analysis, eyes from different groups of mice were extirpated at 
the indicated time point p.i. and snap-frozen in OCT compound (Miles, Elkart, 
IN). Six micron thick sections were cut, air dried in a desiccation box, and stained 
with hematoxylin and eosin (Richard Allen Scientific, Kalamazoo, MI). 
Flow cytometry 
For flow cytometry measurement of the infiltrating cells, four corneas per time 
point per group were collected at indicated time points by dissecting the corneal 
buttons above the limbus by a scalpel. Similarly, two trigeminal ganglias (TGs) 
were collected per time point. Corneas or TGs were digested in Liberase (Roche 
Diagnostics Co., Indianapolis, IN) for 45 min at 37oC. Cervical draining lymph 
nodes (DLNs) and spleens were also collected from individual animals. Single cell 
suspension was prepared as described elsewhere [19]. The Fc receptors were 
blocked with unconjugated anti-CD16/32 (BD Pharmingen, San Diego, CA) for 30 
min. Samples were incubated with fluorescein isothiocyanate (FITC) labeled anti-
Gr-1, anti-CD11b, anti-CD11c, anti-NK1.1, anti- B220, anti-CD19, anti-CD25 
(7D4), anti-CD8 (BD Pharmingen), anti-F4/80 (eBioscience), and PerCpCy5.5 
labeled anti-CD4 (BD Pharmingen), antibody for 30 min. For intracellular 
cytokine staining PE labeled anti-IL-10, anti-IL-17, anti-IFN- γ and FITC labeled 
anti- IFN-γ, anti-TNF-α, antibodies were used (BD Pharmingen, San Diego, CA). 
For Foxp3+IL-10+ cell staining, mice expressing Foxp3-GFP were used and 
GFP+IL-10+ cells were measured in such mice by using intracellular IL-10 
staining. Intracellular staining for IL-10, TNF-α and IFN-γ was performed using 
Fixation/Permeabilization Solution Kit with BD GolgiPlug (BD Bioscience). For 
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intracellular cytokine staining cells were stimulated with anti-CD3 and anti-CD28 
(1μg/ml) or PMA/Ionomycin or UV inactivated HSV (3MOI). Foxp3 staining was 
performed using mouse regulatory T cell staining kit (eBiosciences). All samples 
were collected on a FACScan (BD Biosciences, San Diego, CA), and data were 
analyzed by using cell Quest 3.1 software (BD Biosciences). 
Virus specific CD8+IFN-γ+ staining 
To determine the number of IFN-γ producing CD8+ T cells in the infected draining 
lymph node (DLN) and spleen, intracellular cytokine staining was performed as 
previously described [20]. Single-cell suspension of infected DLN and spleen was 
prepared. 106 cells/well were cultured in 96-well U bottom plates. Cells were left 
untreated or stimulated with SSIEFARL peptide (HSVgB498-505 [synthesized at 
Genemed Synthesis, Inc., CA]) (1 μg/ml) for 5 h at 37oC in 5% CO2. Brefeldin A 
(10 μg/ml) was added to the culture for the intracellular cytokine accumulation. 
Cell surface marker and intracellular cytokine staining for IFN-γ was performed 
using a Cytofix/Cytosperm kit (BD Pharmingen). All samples were collected with 
a FACScan and were analyzed with Cell Quest 3.1 software. 
Purification of CD4+CD25+ and CD4+D25- T cells 
 CD4+CD25+ and CD4+D25- Tregs were purified from the lymph nodes of WT and 
IL-10-/- mice using a Treg isolation kit (Miltenyi Biotec, CA) according to the 
suggested protocol. The purity of cells ranged from 89–92% (Fig. 8A). Accessory 
cells were isolated from spleens of WT mice by depleting Thy1.2+ cells using 
Thy1.2 magnetic beads (Miltenyi Biotec, CA). Thy1.2 depleted cells were 
irradiated before adding to the cultures. CD4+D25- T cells from Thy1.1 B6 animals 
were used for in vitro cultures. 
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Cytokine inhibition and in vitro suppression Assay 
Purified Tregs (5×105/well) from IL-10-/- and WT animals were cultured with 
CD4+CD25- T cells (5×105/well) isolated from naïve and infected WT animals 
along with irradiated splenocytes (1×106/well). Anti-CD3 antibody was added to 
the wells (1μg/ml) .Cells were cultured in a 48 well plate and the culture 
supernatants were collected after 48 h and the levels of IFN-γ and IL-2 measured 
by sandwich ELISA. For in vitro suppression assays, in one of the experiment 
CD4+CD25- T cells from Thy1.1 mice (1×105/well) were labeled with CFSE (0.5 
μM) and were cultured in a 96 well plate with different dilutions of WT or IL10-/- 
CD4+CD25+ T cells (1:1, 1:2, 1:4, 1:8, 1:16, 1:32) in the presence of anti-CD3 
antibody (1μg/ml) and antigen presenting cells (APCs) (2×105/well).   
Cytokine ELISA  
Cervical DLNs from individual mice and six corneas per group were collected at 
the indicated time points. The DLNs and corneas were sonicated and the level of 
IL-6, IL-12 and IL-10 were measured in the supernatants. Similarly, culture 
supernatant from the in vitro suppression assay was collected and the level of IL-2 
and IFN-γ were determined by a standard sandwich ELISA protocol. Anti IL-6, 
IL-12, IL-2, IL-10 and IFN-γ capture and detection antibodies were purchased 
from BD Pharmingen and standard recombinant murine IL-6, IL-12. IL-2, IL-10 
and IFN-γ were obtained from R&D Systems (Minneapolis, MN). Biotinylated 
detection antibodies were purchased from BD Pharmingen. The color reaction was 
developed using ABTS (Sigma-Aldrich, St. Louis, MO) and measured with an 
ELISA reader (Spectramax 340; Molecular Devices, Sunnyvale, CA) at 405 nm. 
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Quantification was performed with Spectramax ELISA reader software version 
1.2.  
Statistical Analysis 
Statistical significance was determined by Student's t test. P < 0.05 was regarded 
as a significant difference between the groups. 
Results 
The absence of IL-10 and depletion of nTreg results in increased SK severity 
The outcome of HSV infection was followed and compared in three groups of 
mice that were age and sex matched and ocularly infected with the same dose of 
HSV-1 RE. The pattern of disease that developed differed significantly in the three 
groups. Thus both IL-10-/- and Treg depleted animals showed heightened 
susceptibility compared to WT animals (Fig.1B and C). Clinical lesions were 
evident in IL-10-/- animals before those in other groups. At 8 days p.i., the 
incidence of SK (lesion score ≥3) was 0 and 30% in WT and IL-10-/- animals 
respectively (not shown). The majority of IL-10-/- animals had developed 
moderately severe lesions (≥3) by 16 day p.i. (90% in the experiment shown in 
Fig. 1B). In contrast, less than 40% of WT animals in the same experiment 
developed ≥ 3 lesions and almost two fold more than WT in the nTreg depleted 
group (Fig. 1B). The pattern of more severe responses in IL-10-/- and Treg 
depleted animals was also evident when the extent of angiogenesis was quantified 
in the different groups (Fig.1E and F). Eyes showing median responses in each 
group were selected for histological analysis. As is evident in Fig. 2A, 
inflammatory reactions were more severe than in WT in both the IL-10-/- and Treg 
depleted animals. In other experiments, corneal samples were collected from 8 
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randomly selected eyes taken from animals at 17 days p.i. to prepare single cell 
suspensions following collagen digestion for phenotypic analysis by flow 
cytometry. Firstly, total viable cell numbers recovered from IL-10-/- and Treg 
depleted animals was greater than WT animals (Fig.2C). In addition, the frequency 
of cells with the neutrophil phenotype was also higher in IL-10-/- and nTreg 
depleted WT as compared to WT animals (Gr1+CD11b+ cells, Fig. 2B). With 
regard to total CD4+ T cells, the highest numbers of such cells were present in the 
eyes of IL-10-/- animals (Fig. 2D). Comparing the ratio of Foxp3+CD4+ T cells to 
Foxp3-CD4+ T cells, the ratio was lower in IL-10-/- animals as compared to WT 
(Fig. 2E). Of note, before infection, the number of Foxp3+ cells in the secondary 
lymphoid tissues was comparable to WT in IL-10-/- mice (data not shown). 
 Cellular analyses were also performed in single cell suspensions of pooled 
trigeminal ganglia from the 3 groups of animals. As with the corneas, 
inflammatory cell numbers were elevated in the TG of IL-10-/- and nTreg depleted 
compared to WT animals (Fig 2F). In addition, the frequency of both CD8+ and 
CD4+ T cells were both elevated compared to WT with the highest frequencies 
present in IL-10-/- animals (Fig. 2G). 
 Along with changes in inflammatory cell influx in the different groups of 
mice, the numbers of IFN-γ and IL-17 producing CD4+ T cells were also measured 
at day 17 in each group by intracellular cytokine staining. Once again the highest 
frequencies of cytokine producing cells were present in the corneas of IL-10-/- 
with Treg depleted showing less and WT the least amount (Fig. 3A-C). By 
intracellular cytokine staining, we also looked for the cytokine producing CD4+ T 
cells in the cervical lymph node and the spleen of these mice. As shown in Fig. 4, 
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about three and eight fold increases in the numbers of CD4+ T cells producing 
IFN-γ and TNF-α were found in the DLN and spleens in the absence of nTregs 
and IL-10 respectively. This increase in proinflammatory mediators in the cornea 
and secondary lymphoid tissues along with higher Treg numbers in IL-10-/- 
animals may mean an inability of nTregs to suppress the disease pathology in the 
proinflammatory milieu [21, 22] or that the pathogenic Th1 type CD4+ T cells 
present at the site are resistant to nTregs mediated suppression [23, 24]. 
We also determined the magnitude of SSIEFARL specific 
(immunodominant epitope in C57BL/6 mice) CD8+ T cell responses and cytokine 
production by CD8+ T cells in these animals. As shown in the Fig. 5A and B, 
higher magnitude of immune responses were noted in the absence of either Tregs 
(three fold) or IL-10 (two fold). Interestingly, in contrast to CD4+ T cells, the 
increase in the total CD8+IFN-γ+ was greater in the absence of nTregs as compared 
to IL-10 which could mean different pathways of immune response generation 
could be influenced by IL-10 and nTregs. 
Treg effects are still evident in IL-10-/- mice 
One explanation for the greater susceptibility of IL-10-/- animals could 
relate to the function of adaptive or natural Tregs. Thus the former cell type is 
usually dependent on IL-10 so would not be expected to be present in IL-10-/- 
animals. Studies in some cases have indicated that Foxp3+ natural Tregs may also 
function at least in part by their production of IL-10 [25]. Another explanation 
could be the dysfunction of nTregs in the presence of high concentration of 
proinflammatory mediators, such as IL-6 and IL-12, at the site [22, 23]. In this 
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regard, higher levels of IL-6 and IL-12 were found in the DLN and corneal lysates 
of IL-10-/- animals as compared to WT (Fig. 6).  
Experiments were performed in older IL-10-/- male mice, which are more 
resistant to HSV induced lesions than the 6-8 weeks old female mice used in 
previous experiments. To evaluate the role of nTregs in controlling SK lesion 
development, Treg depleted IL-10-/- (DEP-IL-10-/-) were compared with non 
depleted IL-10-/- animals As shown in Fig. 7A-D, depletion of CD25+ cells from 
IL-10-/- animals resulted in increased SK lesions (7A and D) as well as angiogenic 
responses (7B and D).At day 20 p.i., 55% eyes in depleted IL-10-/- animals had 
SK scores of ≥ 3 compared with 25% in undepleted IL-10-/- mice (7C). At this 
time point, the SK scores were 2.3 ± 0.3 (p ≤ 0.05) in Treg depleted IL-10-/- mice 
as compared to 1 ± 0.2 in normal IL-10-/- animals. A similar pattern was also 
evident in the development of neovascularization in the depleted IL-10-/- animals. 
At day 20 p.i., Treg depleted IL-10-/- animals had neovascularization scores of 10.8 
± 1.1 as compared to 7.4 ± 1 in control IL-10-/- animals. Additionally, there was 
an earlier onset of SK lesions in the Treg depleted IL-10-/- animals as compared to 
normal IL-10-/- animals.  The incidence of SK at day 12 p.i. was 30 % and 58 % 
in the IL-10-/- and DEP-IL-10-/- group respectively (Fig. 7C). Increased numbers 
of IFN-γ+CD4+ T cells (Fig 7E) and other inflammatory cell influx were also noted 
in the corneas and TG of such animals as compared to the controls (not shown). 
Similarly, as shown in Fig. 7F, the virus specific CTL response, as assessed by the 
frequency and the absolute number of virus specific CD8+IFN-γ+ T cells in the 
secondary lymphoid tissues, was also significantly increased in the absence of 
nTregs in the IL-10-/- animals. These results indicate that even in IL-10-/- animals, 
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nTregs can exert their suppressive activity and that their function could be 
independent of IL-10 in HSV induced corneal immunopathology. 
To support the apparent IL-10 independent in vivo suppressive activity of 
nTregs, we isolated CD4+CD25+ nTregs from uninfected WT and IL-10-/- animals 
and those were cultured with CFSE labeled CD4+CD25- cells isolated from naïve 
and 12 day post infected WT animals. Cells were stimulated with anti-CD3 and 
accessory cells in vitro for 48 h. As is shown in Fig. 8B-D, both groups of nTregs 
could equally suppress the proliferation (Fig. 8B) and cytokine production (Fig. 
8D) from WT CD4+CD25- T cells. 
What is the main cellular source of IL-10 in SK 
Several reports have showed the production of IL-10 by Foxp3+ Tregs [25-27]. To 
determine if in SK nTregs themselves produce IL-10 post infection, we measured 
the IL-10 production using Foxp3-GFP mice at day 5, 11 and 18 p.i. As shown in 
Fig. 8E and table 1, we could not detect substantial numbers of GFP+IL-10+ cells 
in the lymphoid tissues although very few such cells were present in the infected 
corneas at later time points post infection (Table. 1). Additionally, IL-10+IFN-
γ+CD4+ T cells were not evident in either cornea or lymphoid tissues (not shown). 
These data suggest that non regulatory cells could be the major cellular source of 
IL-10 p.i.  
To further study the phenotype of the IL-10 producing cells in the infected 
corneas and secondary lymphoid tissues, intracellular cytokine staining was 
performed with cells taken from infected WT corneas, spleens and DLNs at day 5, 
11, and 20 p.i. The cells were stained with surface markers such as c-kit, Gr-1, 
CD11c, CD11b, B220, CD19, CD25, CD3, NK1.1, and CD4 along with 
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intracellular IL-10. As shown in Table. 1, the majority of the IL-10 producing cells 
in the spleen and DLNs also expressed B220, CD25 and F4/80 markers. More than 
50% of the cells also expressed c-kit and Gr1 markers (data not shown). 
Interestingly, as shown in the Table 1, in the infected corneas non regulatory cells 
with the CD11b+Gr1+ phenotype along with a minor population of Foxp3-CD4+ 
and a few F4/80+ cells produced IL-10. 
Influence of nTreg on IL-10 production 
Since our results indicated that Treg could have IL-10 independent suppression in 
SK, and that these cell types did not constitute a significant part of the IL-10 
producing cell types, we determined whether the activity of nTregs could influence 
the production of IL-10 p.i. In many reports, Tregs were shown to suppress 
immune responses via IL-10 production [8, 28]. Interestingly, as measured by 
intracellular cytokine staining and cytokine ELISA, an increase in the absolute 
number and frequencies of IL-10 producing cells as well as IL-10 proteins was 
noted in the lymphoid tissues in the absence of Tregs in the WT animals as 
compared to undepleted WT animals (Fig. 9A and B). But the mean fluorescence 
intensity (MFI) of IL-10+ cells remained comparable among Treg depleted and 
undepleted WT animals and similar was the case of phenotype of IL-10 producing 
cells (Data not shown). This could be due to the generalized suppressive activity of 
Tregs on the IL-10 producing cell types such as macrophages or DCs or the 
activated CD4+ T cells. In contrast as is evident in the Fig. 9C, the level of IL-10 in 
the corneas of Treg depleted WT mice was lower as compared to undepleted WT 
animals at day 4 and day 9p.i.  
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Discussion 
Many chronic immunoinflammatory diseases are difficult to control 
therapeutically. One such example is SK caused by HSV infection of the eye. It is 
anticipated that control measures will improve once mechanisms involved in 
lesion resolution are all identified and their respective role fully understood. With 
regard to SK, few studies have been done, but reports have demonstrated that 
upregulation of certain cytokines such as IL-10 and TGF-β help resolve lesions 
[29, 30]. Recently, observations in a variety of inflammatory diseases indicate that 
several types of regulatory cells control and resolve inflammatory lesions and 
some of these appear to function by producing either or both IL-10 and TGF-β 
[31]. With SK, natural regulatory T cells were shown previously to influence 
lesions but the mechanisms by which this is achieved were not identified [5].  In 
some systems, nTregs appear to function independently of any cytokine 
production [32], whereas in others IL-10 production is a necessary event [25, 28].  
 In this report, we show that both nTreg and IL-10 participate in the control 
of SK lesion severity, but these two mechanisms proceed largely independently of 
each other. Our results show that the severity of SK lesions become enhanced if 
animals are unable to produce IL-10, because of gene knock out, or have been 
depleted of nTreg. Furthermore, depletion of nTreg in IL-10-/- mice led to even 
higher levels of disease severity than in undepleted IL-10-/- mice. In addition, 
nTreg purified from WT and IL-10-/- animals appeared to be equally suppressive 
in vitro to the activity of non regulatory cells. Few if any Foxp3+CD4+ Treg in 
both the ocular lesions or draining LN were IL-10 producers, In fact, the major 
source of IL-10 appeared to be non T cells such as granulocytes and mononuclear 
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inflammatory cells. Accordingly, these HSV induced immunoinflammatory 
lesions can be modulated independently by both IL-10 and nTreg activity which 
could mean that future novel therapies will need to manipulate both mechanisms to 
achieve maximal effects. 
 The means by which inflammatory lesions are influenced by regulatory T 
cells remain poorly understood especially in responses caused by pathogens [33]. 
In some virus induced immunoinflammatory lesions, some advocate a major role 
for adaptive Tregs induced by antigen in the presence of IL-10 [9, 34]. These so-
called Tr1 cells regulate responses by producing an abundance of IL-10 [9, 34]. 
Their role in SK remains unexplored. In other systems, such as Leishmania 
infections, cells of the nTreg phenotype control lesions but these appear to act by 
producing IL-10 [35, 36]. The same may also be true in other parasite mediated 
lesions as well as in bacterial induced colitis [36, 37]. Our results showing that a 
significant nTreg effect could be demonstrated in mice genetically unable to 
produce IL-10 strongly argues against IL-10 being a dominant mechanism by 
which nTreg act in vivo. Similarly such cells isolated from IL-10-/- mice acted 
equally to those from WT animals in vitro indicating no role for IL-10 to mediate 
their function as others have argued to be the case using different approaches [38].  
It is conceivable that several functional subsets of the Foxp3+ regulatory 
phenotype exist. Those thymic derived autoantigen specific cells, that are 
primarily depleted by pc61 mAb in naïve mice, may function in a different way to 
those converted in vivo from CD4+Foxp3- foreign antigen specific precursors. This 
conversion process was shown recently to occur by several groups [39-41] 
including ourselves [6]. We suspect that the nTregs preexisting at the time of 
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infection are signaled in some way by the HSV infection and these control SK in a 
manner that does not depend on IL-10 production. In contrast, the Foxp3+ Tregs 
that act in more chronic infections may largely represent Foxp3+ converts and 
these may function primarily by producing IL-10. Since we have recently 
succeeded in generating Foxp3+ Treg converts from non regulatory precursors [6], 
we are now in the position to compare these with normal nTregs for their ability to 
modulate SK as well as their dependence on IL-10 production. Such studies are in 
progress. 
 Although our results could not define the site at which IL-10 and nTregs 
function to control SK lesions, we suspect they may be quite different. We 
anticipate that IL-10 acts mainly at the ocular site to control lesions. Moreover, the 
major source of this cytokine was shown to be non regulatory cells having the 
CD11b+Gr1+ and F4/80+ phenotype. Some of these cells may be equivalent to the 
CD11b+Gr1+ myeloid suppressor cells described in some tumor systems [42]. We 
also demonstrated that the IL-10 appeared to act by inhibiting the production of 
proinflammatory cytokines such as IFN-γ, IL-17 and TNF-α. Cells producing such 
cytokines were more abundant in lesions of IL-10-/- than in WT animals. The 
results of several other observations also support a similar anti-inflammatory effect 
of IL-10 [43, 44].  
 Although our observations as well as former reports show the presence of 
Tregs at the site of inflammation [5, 24, 45], we can not assess whether or not they 
exert a suppression effect in the inflamed tissue. In fact whether Tregs function at 
inflammatory site remains debatable. Thus, one report showed that Tregs taken 
from an inflammatory site failed to suppress pathogenic T cells isolated from the 
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lesions when tested in vitro [24], perhaps because their activity was inhibited by 
one or more inflammatory cytokines as has been shown to occur in vitro [22, 23]. 
Interestingly, others have shown that Tregs do proliferate at such sites and that 
they can suppress IFN-γ, although not IL-17 production, by CD4+CD25- T cells 
isolated from the lesion site [45]. In our current study, WT mice depleted of nTreg 
had higher levels of proinflammatory cytokines in the lesions as well as in the 
lymphoid tissues. Conceivably, such cytokines could inhibit their function, but this 
issue requires further evaluations using Tregs isolated from the inflamed cornea at 
different time points p.i.  
A body of evidence favors the idea that nTregs mainly act to regulate in 
lymphoid tissues [46]. Our data favors this idea too. Accordingly, in nTreg 
depleted WT animals the absolute numbers of IL-10 producing cells in the 
draining LN and spleen were increased accounting at least in part for the inhibitory 
effects that occurred. In addition, Treg depletion resulted in better HSV specific 
immune response providing more of the effector cells responsible for mediating 
SK.  
One surprising result of our observations was that an effect of nTreg was 
easy to demonstrate even when the cells were called upon to function in an 
environment rich in cytokines assumed to impair their function. Thus we 
demonstrated marked elevations of cytokines such as IL-6 and IL-12 in the LNs 
and ocular tissues of infected IL-10-/- compared to similarly infected WT animals. 
Despite this, an effect of nTreg depletion was readily apparent in the IL-10-/- 
infected mice. These results may mean either that in the in vivo inflammatory 
environment the inhibitory effects of some cytokines observed in vitro is not a 
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major effect, or that the Tregs function at certain sites such as in LNs where 
effector cells are being generated is not inhibited by inflammatory cytokines. 
Some recent observations on EAE also support the concept that effector cell 
functions in lymphoid sites may be inhibited by Foxp3+ Tregs whereas at the same 
time effectors at lesion site may resist such regulation[24]. These issues are under 
further investigation in the SK system. 
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Figure 1. Increased SK lesions in the absence of IL-10 and nTregs 
A. Percentage of CD4+CD25+ T cells in the spleens at day 4 of the animals 
depleted of nTregs by α-CD25 antibody (pc61 mAb, 0.7mg) treatment. 
Staining for CD25 was performed with FITC labeled anti-CD25 (clone7D4) 
antibody. Left dot plot shows the spleen of an untreated control animal. 
B. The bar diagram demonstrates the percentage severity of each group of mice 
infected with 5 × 105 pfu HSV-1 RE at day 16 p.i. The IL-10-/- and Treg 
depleted mice showed increased incidence (SK score ≥ 3) of disease as 
compared to WT animals. 
C. SK lesion scores of individual eyes at day 16 p.i of WT, DEP-WT (Treg 
depleted WT), and IL-10-/-, mice infected with 5 × 105 pfu infection dose.  
D. SK lesion scores in three groups of mice at different time points p.i. ∗, (P ≤ 
0.05), statistically significant differences as compared to WT control. 
E. Angiogenesis lesion scores of individual eyes at day 16 p.i of WT, DEP-WT, 
and IL-10-/-, mice infected with 5 × 105 pfu infection dose. 
F. Angiogenesis sores at different time points p.i. in the three groups of mice. ∗, 
(P ≤ 0.05), statistically significant differences as compared to WT control. 
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Figure 2.  Increased inflammation in the corneas of mice deficient in IL-10 
and nTregs 
A. Mice were infected with 5 × 105 pfu HSV-1 RE. Mice were terminated at 
Day 17 p.i., and eyes were processed for cryo-section. Hematoxylin and eosin 
staining was carried out on 6-μm sections. The figure shows the pictures of the 
section taken at 10x magnification. 
B. Single-cell suspensions of the infected corneas were prepared from six 
corneas at day 17 p.i. for each group of mice. The cells were labeled for 
Gr1+CD11b+ (PMNs) cells. The dot plots represent the Gr1+CD11b+ cells in 
the WT, DEP-WT and IL-10-/- corneas. The number on the dot plots denotes 
the percentage of inflammatory cells expressing both Gr1+ and CD11b+ 
markers. 
C. The bars represent the total number of viable cells present per cornea of 
different groups of mice. 
D. The cells isolated from infected corneas at day 17 p.i were stained for CD4 
marker and the bars represent the total number of CD4+ T cells present per 
cornea of different groups of mice.  
E. Intra-nuclear staining for CD4+Foxp3+ nTregs was performed with the cells 
isolated from corneas. The bars represent the percentage of CD4+Foxp3+ cells 
present in the total CD4+ T cells per cornea of different groups of mice. 
F. Single-cell suspensions were prepared from four TGs at day 17 p.i. for 
each group of mice. The cells were labeled for Gr1+CD11b+ cells. The dot 
plots represent the Gr1+CD11b+ cells in the WT, DEP-WT and IL-10-/- corneas 
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 Figure. 2 cont. 
 The number on the dot plots denotes the percentage of inflammatory cells 
expressing both Gr1+ and CD11b+ markers in TG. 
G. The cells from TGs were labeled for CD4+ and CD8+ cells. The dot plots 
represent the CD4+ and CD8+ cells in the WT, DEP-WT and IL-10-/- corneas. 
The number on the dot plots denotes the percentage of inflammatory cells 
expressing CD4+ and CD8+ markers. 
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Figure 3. Increased number of CD4+IFN-γ+ T cells in the corneas of mice 
deficient in IL-10 and nTregs 
Single-cell suspensions of corneal cells were prepared from six corneas at day 17 
p.i. Cells were stimulated with either anti-CD3 and anti-CD28 antibody or UV-
HSV. Intracellular IFN-γ staining along with CD4 surface staining was carried out 
as described in materials and methods. The results in the figure represent the data 
from one of two similar experiments. 
A. Dot plots represent the frequencies of CD4+IFN-γ+ T cells when gated on the 
lymphocytes.  
B. The bar diagram demonstrates the total number of CD4+IFN-γ+ in the cornea 
in different groups. 
C. The bar diagram demonstrates the total number of CD4+IL-17+ in the cornea 
in different groups. 
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Figure 4. Increased number of IFN-γ+ and TNF-α+ CD4 T cells in the secondary 
lymphoid tissues of  IL-10-/- mice as compared to nTregs depleted and WT mice 
Single-cell suspensions of the individual spleen and the cervical draining lymph 
nodes (DLN) were prepared from four mice of each group at day 17 p.i. Cells were 
stimulated with either anti-CD3 and anti-CD28 antibody or UV-HSV as described 
in the materials and methods. Intracellular cytokine staining along with CD4 
surface staining was carried out as described in materials and methods. In fig. A 
and B, dot plots represents the frequencies of CD4+IFN-γ+ and CD4+TNF-α+ T 
cells respectively in the lymphoid tissues of different groups of mice when gated 
on the lymphocytes. Bar diagram demonstrates the total number of CD4+IFN-γ+ 
and CD4+TNF-α+ T cells per DLN or Spleen in different groups (N=4 per group). 
*, (P ≤ 0.05), statistically significant differences as compared to WT animals. 
Note: Similar pattern was also noticed in the number of CD4+IL-17+ T cells.  
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Figure 5. Increased number of SSIEFARL peptide specific CD8+IFN-γ+ T cells 
in  the secondary lymphoid tissues of mice deficient in nTregs as compared to 
IL-10-/- and WT 
Single-cell suspensions of the spleen and the cervical lymph nodes were prepared 
from four mice of each group at day 17 p.i. SSIEFARL specific CD8+ IFN-γ+  
staining was carried out as described in materials and methods. 
A. The dot plots in the figure represent the frequencies of CD8+IFN-γ+ cells 
(CD8+ on the x-axis and IFN-γ+ on the y-axis). The numbers on the upper 
right quadrants represent the percentage of CD8+IFN-γ+ T cells in the gated 
population of lymphocytes in the spleens. The plots are representative of 
four animals analyzed per each group (N=4).  
B. The bar diagram demonstrates the total number of double positive cells per 
DLN or Spleen in different groups. ∗, (P ≤ 0.05), and **, (P ≤ 0.01) 
statistically significant differences as compared to WT animals 
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Figure 6. Increased expression of inflammatory mediators in the corneas and 
lymphoid tissues of mice deficient in IL-10 and nTregs 
At the indicated time points, six corneas/group and cervical lymph nodes from 
individual animals were processed to measure the IL-6, and IL-12 levels. Level of 
cytokines were measured in the supernatants of tissue lysates of WT, DEP-WT 
and IL-10-/- animals infected with 5 × 105 pfu HSV-1 RE using sandwich ELISA 
as outlined in materials and methods.  Bar diagrams in Fig. A, and B represent the 
levels of IL-12 and IL-6 in the corneal and DLN lysates of the three groups of 
animals.*, (P ≤ 0.05), statistically significant difference as compared to WT 
animals.  
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Figure 7. Increased SK severity in the absence of nTregs in the IL-10-/- animals 
A. Mean SK lesion scores at different time point p.i. of Treg depleted IL-10-/- 
      (DEP-IL-     
      10-/-) and undepleted IL-10-/- animals. ∗, (P ≤ 0.05), statistically significant        
      differences as compared to undepleted IL-10-/- mice. 
B. Mean angiogenesis scores at different time point p.i. of Treg depleted IL-10-/- 
(DEP-IL-10-/-) and undepleted IL-10-/- animals. ∗, (P ≤ 0.05), statistically 
significant differences as compared to undepleted IL-10-/- mice. 
C. Bar diagram demonstrate the percentage severity (SK score ≥ 3) of both the 
groups of mice at day 14 and day 20 p.i.  
D. Eye pictures showing the lesion severity at day 18 p.i. in IL-10-/- and DEP-IL-
10-/- animals. 
E. Single-cell suspensions of corneal cells were prepared from six corneas at day 
20 p.i. Cells were stimulated with either anti-CD3 and anti-CD28 antibody or 
UV-HSV. Intracellular IFN-γ staining along with CD4 surface staining was 
carried out as described in materials and methods. Bar diagram demonstrate 
the total number of CD4+IFNγ+ T cells/ cornea at day 17 p.i.  
F. Single-cell suspensions of the spleen and the cervical lymph nodes were 
prepared from four mice of each group at day 20 p.i. SSIEFARL specific 
CD8+IFN-γ+  staining was carried out as described in materials and methods. 
The bar diagram demonstrates the total number of double positive cells per 
DLN or spleen in different groups. ∗, (P ≤ 0.05), statistically significant 
differences as compared to undepleted IL-10-/- animals. 
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Figure 8. nTregs from both IL-10-/- and WT animals can equally suppress the 
proliferation and cytokine production from conventional T cell isolated from WT 
animals  
CD4+CD25+ and CD4+CD25- cells were isolated as described in materials and 
methods and were cultured in the presence of irradiated splenocytes and anti-CD3. 
Culture supernatants were collected at 48 hr and the level of cytokines was 
analyzed by sandwich ELISA. For measuring proliferation of non Tregs, 
CD4+CD25- from Thy1.1 mice were labeled with CFSE and the extent of 
suppression activity was assessed from the intensity of CFSE staining. 
A. Dot plots show the purity of isolated CD4+CD25+ T cells from WT and IL-10-/- 
mice.  
B. Histograms demonstrate the suppression of proliferation of conventional T 
cells by nTregs isolated from IL-10-/- (lower panel) and WT (upper panel) 
animals. Proliferation of CD4+CD24- T cells are shown at 1:1, 1:4 and 1:8 
dilutions of CD4+ CD25+ nTregs. Grey dotted lines denote the division of 
CD4+CD25- T cells in the absence of nTregs and the solid lines show the 
suppression in the presence of nTregs. 
C. Bar diagrams show the levels of IFN-γ in the 48 hr culture supernatant in the 
presence and absence of nTregs. As shown in the figure, both the nTregs could 
equally suppress the cytokine production. 
D. Bar diagrams show the levels of IL-2 in the 48 hr culture supernatant in the 
presence or absence of nTregs. 
E. GFP-Foxp3 mice were infected with HSV-RE and intracellular staining for IL-
10 was performed as outlined in the materials and methods. As shown in the  
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Figure 8 cont. 
dot plots, no IL-10+ and GFP+ cells were detected in the lymphoid tissues after 
infection. 
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Figure 9. A. Tregs do not produce IL-10 but can influence the IL-10 production 
from other cell types in the lymphoid tissues 
To ascertain the effect of Tregs on IL-10 production, total numbers of IL-10+ cells 
were measured in the Treg depleted and undepleted animals.  A. The bar diagram 
demonstrates an increase in the number of IL-10+ cells in the lymphoid tissues of 
Treg depleted animals. B. The bar diagram demonstrates an increase in the IL-10 
and IFN-γ protein levels in the Treg depleted animals as compared to undepleted 
WT animals at day 6 p.i. C. The bar diagram demonstrates the level IL-10 in the 
corneal lysates of Treg depleted animals as compared to undepleted WT animals at 
day 4 and 9 p.i. ∗, (P ≤ 0.05), statistically significant differences as compared to 
undepleted WT animals. 
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Table 1. 
Phenotype of IL-10 producing cells in various tissues 
 
% of Total IL-10+ cells Days 
p.i. 
Surface markers 
Cornea Spleen DLN 
5 CD4+ 30 <5 5±2 
 Foxp3+ 0 UD UD 
 Gr1+CD11b+ 50 - - 
 F4/80+ 10 6±2.6 <5 
 B220+ - 62±4.2 65±11 
 CD25+ - 40±4 45±8 
11 CD4+ 5-10 7±2.5 5±3.2 
 Foxp3+ 2 UD UD 
 Gr1+CD11b+ 80 - - 
 F4/80+ 5 14±3.2 7.6±3 
 B220+ - 77±4.3 89±2 
 CD25+ - 65±3 73±4.3 
20 CD4+ 5-10 UD UD 
 Foxp3+ 2-5 <1 <1 
 Gr1+CD11b+ 70-80 - - 
 F4/80+ <5 20±5 25±2.5 
 B220+ - 83±3 84±4 
 CD25+ - 55±5 60.5±6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     * The number of Foxp3+IL-10+ cell number is determined by using       
GFP+IL10+ cell      number. After day 20 p.i.an increase in the number of these 
double positive cells was noticed in the infected corneas but not in the 
lymphoid tissues.  
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